{"meta":{"query_hash":"11ddc1b80af9","filters":{"venue":"Diabetes Therapy"},"cohort_total":80,"direct_labels_cover":0,"predictions_cover":80,"exported":80,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/11ddc1b80af9","api":"https://metacan.xera.ac/api/v1/cohort?venue=Diabetes+Therapy"},"results":[{"id":"W1974658403","doi":"10.1007/s13300-014-0080-0","title":"Cost–Utility Analysis of Glucagon-Like Peptide-1 Agonists Compared with Dipeptidyl Peptidase-4 Inhibitors or Neutral Protamine Hagedorn Basal Insulin as Add-On to Metformin in Type 2 Diabetes in Sweden","year":2014,"lang":"en","type":"article","venue":"Diabetes Therapy","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Health Economics","funders":"Lunds Universitet; Vetenskapsrådet; Novo Nordisk; Sanofi; Eli Lilly and Company","keywords":"Medicine; Metformin; Internal medicine; Endocrinology; Sitagliptin; Insulin; Type 2 Diabetes Mellitus; Diabetes mellitus","score_opus":0.03225883259212647,"score_gpt":0.29655709969669153,"score_spread":0.26429826710456505,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1974658403","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947404,0.00026035975,0.0000051287243,0.0003060376,0.00013245933,0.0032535521,0.000039791423,0.0000929132,0.0011693469],"genre_scores_gemma":[0.9961921,0.000086179156,0.00055237475,0.0013024032,0.00007783391,0.00065501634,0.0004105305,0.00007630191,0.00064726046],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9964627,0.00025777883,0.0008851926,0.00085599616,0.00057320844,0.00096512947],"domain_scores_gemma":[0.99791616,0.0003917475,0.0002706709,0.0009092648,0.00017937015,0.0003327816],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009351201,0.0006225133,0.0016984938,0.0014685099,0.000066129156,0.000060195503,0.0003253363,0.00015688138,0.00033561618],"category_scores_gemma":[0.00016050483,0.00044414797,0.00025790956,0.0033338913,0.00017300586,0.00019860393,0.00009222119,0.00031266795,0.00006789309],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003822907,0.003137696,0.92733485,0.00020077199,0.0022122324,0.000030443045,0.0010981523,0.000680137,0.004827523,0.00004697436,0.00085571664,0.055752583],"study_design_scores_gemma":[0.0109035475,0.007989169,0.90217084,0.0006859748,0.00073138915,2.1382486e-7,0.0003027758,0.0039583645,0.0658451,0.000048348687,0.006684886,0.00067940785],"about_ca_topic_score_codex":0.00019269928,"about_ca_topic_score_gemma":0.0014179725,"teacher_disagreement_score":0.061017577,"about_ca_system_score_codex":0.00022979475,"about_ca_system_score_gemma":0.00012712837,"threshold_uncertainty_score":0.99980104},"labels":[],"label_agreement":null},{"id":"W2023859994","doi":"10.1007/s13300-012-0013-8","title":"Efficacy and Safety of Taspoglutide Versus Sitagliptin for Type 2 Diabetes Mellitus (T-Emerge 4 Trial)","year":2012,"lang":"en","type":"article","venue":"Diabetes Therapy","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"F. Hoffmann-La Roche","keywords":"Sitagliptin; Medicine; Placebo; Metformin; Internal medicine; Sitagliptin Phosphate; Clinical endpoint; Gastroenterology; Diabetes mellitus; Type 2 diabetes; Randomized controlled trial; Endocrinology","score_opus":0.043983561132298676,"score_gpt":0.3092227144635877,"score_spread":0.265239153331289,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2023859994","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97340167,0.022046905,0.000006574674,0.00028792914,0.0008951866,0.0021315669,0.000024531388,0.0000624089,0.0011432446],"genre_scores_gemma":[0.9947937,0.0028253603,0.0009601597,0.00026565546,0.0003658825,0.00015776427,0.00013986629,0.000050774375,0.00044085065],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985336,0.000047562327,0.00035786413,0.00025179095,0.00019503753,0.0006141401],"domain_scores_gemma":[0.99874187,0.0004757889,0.00014057416,0.00036419553,0.000086911314,0.00019066704],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044793397,0.000258314,0.0005708796,0.00012349442,0.000072342074,0.000013418504,0.000092521834,0.00009089933,0.00017339046],"category_scores_gemma":[0.00012251972,0.00020583412,0.00015756059,0.00020157734,0.000094621006,0.00013195621,0.00003970172,0.00006902263,0.000023870138],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.11958282,0.0049767387,0.14186403,0.00064687966,0.0062407926,0.0000012964133,0.0012161137,0.0000044814137,0.031159041,0.005908486,0.0067026187,0.6816967],"study_design_scores_gemma":[0.37478453,0.017236475,0.108930305,0.00024729938,0.0016186445,1.2816184e-7,0.00019485442,0.00012534343,0.104655504,0.0003073143,0.3910507,0.00084891584],"about_ca_topic_score_codex":0.0000020854457,"about_ca_topic_score_gemma":6.0112774e-7,"teacher_disagreement_score":0.68084776,"about_ca_system_score_codex":0.000042580068,"about_ca_system_score_gemma":0.00002092542,"threshold_uncertainty_score":0.83936715},"labels":[],"label_agreement":null},{"id":"W2041650397","doi":"10.1007/s13300-014-0065-z","title":"Early Discontinuation and Restart of Insulin in the Treatment of Type 2 Diabetes Mellitus","year":2014,"lang":"en","type":"article","venue":"Diabetes Therapy","topic":"Diabetes Management and Research","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Eli Lilly (Canada)","funders":"Eli Lilly and Company","keywords":"Medicine; Discontinuation; Diabetes mellitus; Insulin; Type 2 Diabetes Mellitus; Type 2 diabetes; Internal medicine; Intensive care medicine; Endocrinology","score_opus":0.022515987662305347,"score_gpt":0.2845708432846278,"score_spread":0.26205485562232245,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2041650397","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922745,0.005877574,0.0000011277639,0.0005087539,0.000040723386,0.00049543165,0.0000022855395,0.000008003193,0.0007915662],"genre_scores_gemma":[0.99675053,0.0028199484,0.00007027169,0.000089804904,0.00005075333,0.00002782833,0.000018910472,0.000011146363,0.0001608213],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990979,0.00013122195,0.00021381183,0.00013813925,0.000217787,0.00020116505],"domain_scores_gemma":[0.9993376,0.00024134982,0.00006989639,0.00026408266,0.000060722916,0.000026363994],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004828351,0.00010031677,0.00028575346,0.00013907757,0.000019716561,0.000013628049,0.00008441856,0.000040885167,0.000022842776],"category_scores_gemma":[0.00004395032,0.00005691954,0.000050697756,0.00025883137,0.00012927994,0.000051123836,0.000010035985,0.00004963014,0.0000034981158],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008721986,0.0006928891,0.5796788,0.000054596647,0.00009324087,3.4833954e-7,0.0014845723,0.000002229475,0.008291921,0.00040854787,0.00004493475,0.40916076],"study_design_scores_gemma":[0.0027765646,0.0058730957,0.9616976,0.00009409731,0.00003431234,1.4325764e-8,0.000094831725,0.00070760166,0.019382903,0.0009969397,0.008261249,0.00008079183],"about_ca_topic_score_codex":0.000015106367,"about_ca_topic_score_gemma":0.0000047967155,"teacher_disagreement_score":0.40907997,"about_ca_system_score_codex":0.000011457513,"about_ca_system_score_gemma":0.000010892179,"threshold_uncertainty_score":0.23211114},"labels":[],"label_agreement":null},{"id":"W2060423751","doi":"10.1007/s13300-012-0007-6","title":"Cost of Self-Monitoring of Blood Glucose in Canada among Patients on an Insulin Regimen for Diabetes","year":2012,"lang":"en","type":"article","venue":"Diabetes Therapy","topic":"Diabetes Management and Education","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Novo Nordisk","keywords":"Medicine; Diabetes mellitus; Insulin; Regimen; Pharmacy; Type 2 diabetes; Medical prescription; Diabetes management; Internal medicine; Intensive care medicine; Emergency medicine; Endocrinology; Pharmacology; Family medicine","score_opus":0.018317023433571805,"score_gpt":0.2594698090616091,"score_spread":0.2411527856280373,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2060423751","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977291,0.0006176848,2.3390129e-7,0.00004139122,0.0004665362,0.00093632407,0.000016874734,0.000017844772,0.00017399895],"genre_scores_gemma":[0.9990174,0.00010325586,0.00027204823,0.0001299477,0.00017202969,0.00015289862,0.00009883485,0.000031659245,0.000021888693],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99879164,0.000043585384,0.0003342564,0.00016244409,0.00023961013,0.00042849066],"domain_scores_gemma":[0.9991257,0.00013848822,0.00020516038,0.00029158688,0.00011323418,0.00012580458],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030841213,0.0001528698,0.00034295768,0.00015961585,0.000023859593,0.000006107467,0.00011827304,0.000049626746,0.000016057958],"category_scores_gemma":[0.000057099278,0.00013989289,0.000051779687,0.00021519599,0.000025302214,0.00019791265,0.000013724789,0.00007563345,8.441544e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000045886944,0.0014997568,0.9694104,0.00014837385,0.00015389301,5.4314675e-8,0.0006471387,0.000004977189,0.0023954308,0.000014311014,0.00011125346,0.025568532],"study_design_scores_gemma":[0.002297341,0.00060146075,0.8146442,0.00014858131,0.000059741986,2.691125e-9,0.00016429703,0.00005252514,0.18148227,0.0000150710175,0.00042873668,0.00010576098],"about_ca_topic_score_codex":0.0069954023,"about_ca_topic_score_gemma":0.0018564231,"teacher_disagreement_score":0.17908683,"about_ca_system_score_codex":0.00013251093,"about_ca_system_score_gemma":0.000115797935,"threshold_uncertainty_score":0.9996171},"labels":[],"label_agreement":null},{"id":"W2129617225","doi":"10.1007/s13300-015-0118-y","title":"Associations Between Glycemic Control, Depressed Mood, Clinical Depression, and Diabetes Distress Before and After Insulin Initiation: An Exploratory, Post Hoc Analysis","year":2015,"lang":"en","type":"article","venue":"Diabetes Therapy","topic":"Diabetes Management and Education","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Eli Lilly (Canada)","funders":"Eli Lilly and Company","keywords":"Medicine; Glycemic; Depression (economics); Distress; Internal medicine; Diabetes mellitus; Glycated hemoglobin; Observational study; Type 2 diabetes; Confounding; Mood; Post-hoc analysis; Patient Health Questionnaire; Psychiatry; Insulin; Endocrinology; Clinical psychology; Depressive symptoms","score_opus":0.02949611979113506,"score_gpt":0.31268760597105916,"score_spread":0.28319148617992407,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2129617225","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955198,0.0023555658,0.000031859818,0.00095003,0.00015624713,0.0005160261,0.0002780308,0.00010829989,0.00008413578],"genre_scores_gemma":[0.99555475,0.000236772,0.0001627393,0.0013113011,0.0005323509,0.00015241395,0.0019833667,0.000039763952,0.000026537391],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979146,0.00026784066,0.00057341804,0.0005201564,0.00032996165,0.00039402462],"domain_scores_gemma":[0.998163,0.00028393787,0.0002710865,0.00045009292,0.00035433972,0.00047755422],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007847912,0.00027106702,0.00073396746,0.00028297072,0.00012389457,0.00016503174,0.00012600965,0.00020235694,0.000033884902],"category_scores_gemma":[0.0002516936,0.00023254182,0.00013395213,0.0004713558,0.00015520677,0.00060603925,0.00005539332,0.00020652486,0.000009685947],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024632365,0.00026473156,0.96635777,0.000017256672,0.0011690117,8.565453e-7,0.0008065513,0.0000032713226,0.000056181845,0.0000066009134,0.00014539597,0.030926064],"study_design_scores_gemma":[0.005578457,0.0010935926,0.99019283,0.000037041675,0.0012519868,4.745553e-8,0.0002149384,0.00058715674,0.00013238785,0.00035586278,0.00031745614,0.00023826247],"about_ca_topic_score_codex":0.0000074678524,"about_ca_topic_score_gemma":0.00005369053,"teacher_disagreement_score":0.030687802,"about_ca_system_score_codex":0.000047628746,"about_ca_system_score_gemma":0.00005899515,"threshold_uncertainty_score":0.948278},"labels":[],"label_agreement":null},{"id":"W2172438155","doi":"10.1007/s13300-015-0142-y","title":"IDegLira Versus Alternative Intensification Strategies in Patients with Type 2 Diabetes Inadequately Controlled on Basal Insulin Therapy","year":2015,"lang":"en","type":"article","venue":"Diabetes Therapy","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Novo Nordisk Fonden; Novo Nordisk","keywords":"Medicine; Liraglutide; Insulin glargine; Insulin degludec; Type 2 diabetes; Insulin aspart; Hypoglycemia; Internal medicine; Insulin; Glycated hemoglobin; Lixisenatide; Diabetes mellitus; Glucagon-like peptide 1 receptor; Endocrinology; Agonist","score_opus":0.04309277245387194,"score_gpt":0.2779275746307542,"score_spread":0.23483480217688224,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2172438155","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99270725,0.0010413488,0.0000027686388,0.0004783363,0.00045722933,0.0018793617,0.000006624244,0.000097775905,0.0033292836],"genre_scores_gemma":[0.99756444,0.0003317936,0.00011459622,0.0012560501,0.00010222713,0.00024304433,0.00022714648,0.000056393656,0.00010430269],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99812394,0.00013106894,0.00034616212,0.00042354196,0.000499684,0.00047557504],"domain_scores_gemma":[0.9986268,0.0001951119,0.00018328839,0.00040321448,0.00043332754,0.00015825691],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00030723767,0.0003721329,0.0006674857,0.00031072574,0.000041164185,0.00008717973,0.00015997158,0.00009046396,0.000051687388],"category_scores_gemma":[0.00009933657,0.00024810844,0.00008298128,0.00040210603,0.00010159175,0.00027987082,0.000021162825,0.00018556864,0.00007857943],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.060999207,0.0050668493,0.78327554,0.000033731892,0.0029429279,0.000015319261,0.0021674146,0.00026041493,0.0008051876,0.0017621568,0.0012463033,0.14142497],"study_design_scores_gemma":[0.21962912,0.03477958,0.728529,0.00025095738,0.00011939907,2.4549834e-8,0.0008884807,0.00088633044,0.009328059,0.001579569,0.0033074308,0.0007020453],"about_ca_topic_score_codex":0.000017554665,"about_ca_topic_score_gemma":0.0000071815753,"teacher_disagreement_score":0.15862992,"about_ca_system_score_codex":0.00020302155,"about_ca_system_score_gemma":0.000108010645,"threshold_uncertainty_score":0.99999714},"labels":[],"label_agreement":null},{"id":"W2276028032","doi":"10.1007/s13300-016-0155-1","title":"A Network Meta-analysis Comparing Exenatide Once Weekly with Other GLP-1 Receptor Agonists for the Treatment of Type 2 Diabetes Mellitus","year":2016,"lang":"en","type":"review","venue":"Diabetes Therapy","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sheridan College; Public Health Ontario","funders":"AstraZeneca","keywords":"Exenatide; Medicine; Lixisenatide; Tolerability; Dulaglutide; Metformin; Liraglutide; Internal medicine; Type 2 diabetes; Glycated hemoglobin; Glucagon-like peptide 1 receptor; Discontinuation; Type 2 Diabetes Mellitus; Pharmacology; Diabetes mellitus; Adverse effect; Endocrinology; Agonist; Insulin; Receptor","score_opus":0.1266099849112865,"score_gpt":0.3423086737592977,"score_spread":0.2156986888480112,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2276028032","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0004982382,0.9933073,0.00006741416,0.00031177863,0.0002174646,0.004975562,0.00017450785,0.000087596,0.00036016374],"genre_scores_gemma":[0.000261106,0.98986655,0.0013002082,0.00027887736,0.0004175616,0.0032579356,0.0004515538,0.00018418685,0.0039820075],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9967387,0.0002268794,0.0009062012,0.00080264994,0.00044721912,0.0008783922],"domain_scores_gemma":[0.9954019,0.0018954598,0.000917087,0.001423662,0.00020704039,0.00015485795],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00048273872,0.0010277865,0.006902353,0.00029745506,0.00016810991,0.00007770387,0.00041650777,0.00019574136,0.00054011046],"category_scores_gemma":[0.000019630468,0.00042824866,0.0038268056,0.0010562277,0.00020831425,0.000070985065,0.00003605945,0.00011205261,0.000050918043],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008178982,0.00052756455,0.0010125285,0.0011494345,0.4135447,8.480332e-7,0.00006660178,0.000016620505,0.0000022001125,0.00012555785,0.0009406808,0.58253145],"study_design_scores_gemma":[0.0011579037,0.0020119406,0.00003259459,0.0010073386,0.2780427,6.641645e-8,0.000006473443,0.000023828148,0.000054159387,0.0000349348,0.71728945,0.00033859874],"about_ca_topic_score_codex":0.000015287333,"about_ca_topic_score_gemma":0.000014868014,"teacher_disagreement_score":0.71634877,"about_ca_system_score_codex":0.00025256048,"about_ca_system_score_gemma":0.00012234451,"threshold_uncertainty_score":0.99981695},"labels":[],"label_agreement":null},{"id":"W2299595115","doi":"10.1007/s13300-016-0163-1","title":"Simultaneous Reduction in Both HbA1c and Body Weight with Canagliflozin Versus Glimepiride in Patients with Type 2 Diabetes on Metformin","year":2016,"lang":"en","type":"article","venue":"Diabetes Therapy","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; University of Toronto","funders":"Janssen Research and Development","keywords":"Canagliflozin; Glimepiride; Medicine; Metformin; Glycemic; Hypoglycemia; Type 2 diabetes; Diabetes mellitus; Adverse effect; Internal medicine; Urology; Weight loss; Endocrinology; Gastroenterology; Obesity","score_opus":0.006691807101830577,"score_gpt":0.21757832562927343,"score_spread":0.21088651852744286,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2299595115","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973843,0.00058051076,6.3822984e-7,0.00033867708,0.00014862203,0.0009389088,0.0000076604765,0.000053306954,0.0005473394],"genre_scores_gemma":[0.998644,0.00039841747,0.00019462043,0.00020663899,0.000052174753,0.0000838575,0.000045110115,0.000050706007,0.00032445646],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985205,0.000046405134,0.0002142944,0.00042557134,0.00028643728,0.0005068241],"domain_scores_gemma":[0.99922913,0.0001949535,0.000083921834,0.00031539044,0.000059590566,0.00011703124],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013644443,0.00029726216,0.0004184084,0.0003204492,0.000036697442,0.000021390659,0.0000742106,0.00007080156,0.00005240702],"category_scores_gemma":[0.000033892306,0.00016389914,0.000027231215,0.00036523087,0.00009782721,0.00016806676,0.000018717235,0.00009895336,0.000014697627],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00411349,0.0008010287,0.8742461,0.00003215421,0.00042476406,0.000026802067,0.00013269219,0.000012818891,0.0015656048,0.00006463026,0.00014424617,0.11843564],"study_design_scores_gemma":[0.0518069,0.02176671,0.89747566,0.0010003123,0.00021153443,3.3835775e-7,0.000074795964,0.00015005823,0.01872161,0.000110391906,0.007985676,0.00069601],"about_ca_topic_score_codex":0.000046144305,"about_ca_topic_score_gemma":0.000119049604,"teacher_disagreement_score":0.11773963,"about_ca_system_score_codex":0.00022017406,"about_ca_system_score_gemma":0.000038255854,"threshold_uncertainty_score":0.6683613},"labels":[],"label_agreement":null},{"id":"W2320992886","doi":"10.1007/s13300-016-0166-y","title":"Clinical Effectiveness and Safety of Analog Glargine in Type 1 Diabetes: A Systematic Review and Meta-Analysis","year":2016,"lang":"en","type":"review","venue":"Diabetes Therapy","topic":"Diabetes Management and Research","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Conselho Nacional de Desenvolvimento Científico e Tecnológico; Academy of Medical Sciences","keywords":"Medicine; Meta-analysis; Type 2 diabetes; Insulin glargine; Diabetes mellitus; Systematic review; Intensive care medicine; MEDLINE; Pharmacology; Internal medicine; Endocrinology","score_opus":0.10504614652268317,"score_gpt":0.43005059029307335,"score_spread":0.3250044437703902,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2320992886","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00039023193,0.9934624,0.0000025281693,0.000109992965,0.0000378031,0.005809253,0.00006510991,0.000021616699,0.00010105781],"genre_scores_gemma":[0.00023233634,0.9984213,0.000031774092,0.00027922203,0.000029325834,0.0005378885,0.000089710535,0.00005972306,0.000318684],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99410444,0.002436726,0.001827793,0.0007340859,0.00041155206,0.00048540227],"domain_scores_gemma":[0.9950895,0.0028782026,0.00069655594,0.0009529291,0.00019453517,0.00018831217],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.006933862,0.00058153766,0.015845189,0.00084909104,0.000032602908,0.000027085982,0.00028229135,0.00030047007,0.00026435498],"category_scores_gemma":[0.00062365073,0.00029268186,0.0021912912,0.0017897793,0.00027349728,0.00007451901,0.00015664435,0.00039391365,0.000017692291],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000014218691,0.00013033999,0.0022971954,0.72688806,0.17450584,0.0000037907864,0.0000037107204,2.0723492e-8,3.606074e-7,0.000022616272,0.000022907383,0.09611092],"study_design_scores_gemma":[0.0011976315,0.00064044516,0.0017642934,0.1880094,0.7740566,3.478373e-7,0.0000015816807,0.0000071099844,9.981779e-7,0.00004246186,0.03385086,0.00042823292],"about_ca_topic_score_codex":0.0000013227143,"about_ca_topic_score_gemma":0.000001267486,"teacher_disagreement_score":0.5995508,"about_ca_system_score_codex":0.000045553472,"about_ca_system_score_gemma":0.00008054235,"threshold_uncertainty_score":0.99995255},"labels":[],"label_agreement":null},{"id":"W2567557402","doi":"10.1007/s13300-016-0220-9","title":"Lack of Evidence to Guide Deprescribing of Antihyperglycemics: A Systematic Review","year":2016,"lang":"en","type":"review","venue":"Diabetes Therapy","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; University of Waterloo; Women's College Hospital; University of Toronto; Ottawa Hospital; University of Ottawa; Bruyère","funders":"Canadian Institutes of Health Research","keywords":"Deprescribing; Medicine; MEDLINE; Type 2 diabetes; Glycemic; Cochrane Library; Hypoglycemia; CINAHL; Glycated hemoglobin; Polypharmacy; Adverse effect; Intensive care medicine; Systematic review; Diabetes mellitus; Meta-analysis; Nursing; Internal medicine; Psychological intervention","score_opus":0.23377379864574205,"score_gpt":0.4214522913955017,"score_spread":0.18767849274975967,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2567557402","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007403831,0.99198765,0.000009436907,0.00012030177,0.0001191738,0.0070925453,0.000034297434,0.00004462588,0.00051794923],"genre_scores_gemma":[0.0000223364,0.9964542,0.0003352052,0.0007669455,0.000058228907,0.0007357086,0.000029679875,0.00008417594,0.0015135644],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9966861,0.00023683763,0.0017481382,0.00046507618,0.00047480807,0.00038904924],"domain_scores_gemma":[0.9965932,0.0006224626,0.0010204526,0.0013904377,0.00023242108,0.00014106251],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00089691323,0.00052255596,0.0059077363,0.00032704385,0.000018384368,0.000010523295,0.0004710613,0.00013621115,0.00010772277],"category_scores_gemma":[0.0006152964,0.00026574038,0.0010304828,0.00050058524,0.000060760074,0.00008491188,0.00012188755,0.0000981795,0.000113690454],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000005763683,0.00008132037,0.00005689526,0.6755111,0.0013358116,0.0000028464256,0.000016702455,1.4465465e-8,0.000033006472,0.000023421373,0.0011930076,0.32174012],"study_design_scores_gemma":[0.00028234773,0.0003832141,0.000002291674,0.73164284,0.0038803697,9.858455e-7,0.0000022845031,2.7898645e-7,0.0000946083,0.000006052077,0.26351553,0.00018920808],"about_ca_topic_score_codex":0.0000038859566,"about_ca_topic_score_gemma":2.6116817e-7,"teacher_disagreement_score":0.3215509,"about_ca_system_score_codex":0.00013638442,"about_ca_system_score_gemma":0.00015008547,"threshold_uncertainty_score":0.9999795},"labels":[],"label_agreement":null},{"id":"W2589084718","doi":"10.1007/s13300-017-0232-0","title":"Effects of Canagliflozin on Serum Magnesium in Patients With Type 2 Diabetes Mellitus: A Post Hoc Analysis of Randomized Controlled Trials","year":2017,"lang":"en","type":"article","venue":"Diabetes Therapy","topic":"Magnesium in Health and Disease","field":"Nursing","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"European Association for the Study of Diabetes; Mitsubishi Tanabe Pharma Corporation; Canada Research Chairs; European Foundation for the Study of Diabetes; AstraZeneca; Janssen Scientific Affairs; American Diabetes Association","keywords":"Canagliflozin; Medicine; Post-hoc analysis; Internal medicine; Magnesium; Placebo; Gastroenterology; Diabetes mellitus; Type 2 diabetes; Endocrinology; Type 2 Diabetes Mellitus; Randomized controlled trial; Hypermagnesemia; Hypomagnesemia; Chemistry; Pathology","score_opus":0.008613324038143825,"score_gpt":0.27048372605943427,"score_spread":0.26187040202129047,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2589084718","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98887646,0.006022846,3.8679826e-7,0.00030036198,0.0005479448,0.0039745052,0.00011186572,0.000022193191,0.00014343514],"genre_scores_gemma":[0.9988233,0.00007742085,0.000032476837,0.00063455594,0.000055765628,0.00026488502,0.000060438666,0.000033118053,0.000018050398],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9952922,0.0019779943,0.0013559593,0.0003593018,0.000501045,0.000513498],"domain_scores_gemma":[0.9914801,0.005333157,0.0017839962,0.00077947596,0.00043245094,0.0001908139],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031394856,0.00034503033,0.0052678147,0.00075226615,0.00012109258,0.000057533147,0.0003634001,0.00013047204,0.00013866494],"category_scores_gemma":[0.005464407,0.0002157231,0.00081340986,0.00043748267,0.00021717358,0.0001277309,0.000019434541,0.00011464818,0.000002526527],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.47639057,0.0009043059,0.50548214,0.0007203542,0.0014014775,0.0000010717162,0.0002715585,0.000053352567,0.0010816448,0.000026393906,0.000015270203,0.013651856],"study_design_scores_gemma":[0.3995424,0.002544186,0.58381253,0.00010338211,0.003299794,1.6420915e-9,0.000014543128,0.0005770743,0.009768587,0.00009819533,0.000006582315,0.0002327365],"about_ca_topic_score_codex":0.00037925842,"about_ca_topic_score_gemma":0.00011211434,"teacher_disagreement_score":0.07833037,"about_ca_system_score_codex":0.000043278967,"about_ca_system_score_gemma":0.00008255602,"threshold_uncertainty_score":0.8796933},"labels":[],"label_agreement":null},{"id":"W2788976924","doi":"10.1007/s13300-018-0375-7","title":"Insulin Matters: A Practical Approach to Basal Insulin Management in Type 2 Diabetes","year":2018,"lang":"en","type":"article","venue":"Diabetes Therapy","topic":"Diabetes Management and Research","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University; Dalhousie University; Centre for Family Medicine; Horizon Health Network; Island Health; Lakeshore General Hospital; University of Toronto; Western University; St. Michael's Hospital; Trillium Health Centre; Saint John Regional Hospital; LMC Diabetes & Endocrinology (Canada); Alberta Health Services; Nova Scotia Health Authority; Credit Valley Hospital; Health Sciences Centre; McMaster University; Winnipeg Regional Health Authority","funders":"Sanofi","keywords":"Medicine; Type 2 diabetes; Prediabetes; Glycemic; Diabetes mellitus; Intensive care medicine; Insulin resistance; Diabetes management; Nephropathy; Endocrinology","score_opus":0.04182465527090936,"score_gpt":0.3330721675094244,"score_spread":0.2912475122385151,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2788976924","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95935374,0.00070991484,0.000054169643,0.009116222,0.0003208314,0.0017368296,0.0000039196793,0.00013057927,0.02857377],"genre_scores_gemma":[0.9585537,0.0003896604,0.012429166,0.024934715,0.0006486493,0.0003381031,0.000078023106,0.00010898111,0.0025190285],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9972295,0.00014576086,0.00038899126,0.0006312353,0.00060544047,0.0009990428],"domain_scores_gemma":[0.9987473,0.000110463225,0.000060829156,0.0006371592,0.00015187608,0.0002923695],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008799138,0.00030612998,0.0004717882,0.00065730535,0.00008212902,0.00011325345,0.00030461352,0.00012811401,0.00045608057],"category_scores_gemma":[0.00009325517,0.0002498224,0.00009667696,0.0013444709,0.00019295426,0.00018734655,0.0002297946,0.00033239284,0.0012475724],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018225245,0.006683173,0.1768571,0.00076735264,0.0016267907,0.000073183386,0.0015903397,0.000017648317,0.01015627,0.0022982606,0.13122436,0.666883],"study_design_scores_gemma":[0.012840026,0.0058262968,0.48752442,0.0005395103,0.00014179887,7.447281e-7,0.00057001744,0.0067237443,0.012838089,0.0021189274,0.4695751,0.001301297],"about_ca_topic_score_codex":0.00000485191,"about_ca_topic_score_gemma":0.0000022407849,"teacher_disagreement_score":0.6655817,"about_ca_system_score_codex":0.00010077339,"about_ca_system_score_gemma":0.00004505487,"threshold_uncertainty_score":0.9999954},"labels":[],"label_agreement":null},{"id":"W2807496383","doi":"10.1007/s13300-018-0448-7","title":"Successful Management of Poorly Controlled Type 2 Diabetes with Multidisciplinary Neurobehavioral Rehabilitation: A Case Report and Review","year":2018,"lang":"en","type":"article","venue":"Diabetes Therapy","topic":"Botulinum Toxin and Related Neurological Disorders","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Hamilton Health Sciences","funders":"","keywords":"Medicine; Type 2 diabetes; Rehabilitation; Glycemic; Diabetes mellitus; Depression (economics); Type 2 Diabetes Mellitus; Anxiety; Physical therapy; Intensive care medicine; Psychiatry; Endocrinology","score_opus":0.015083075822666143,"score_gpt":0.29526393161513165,"score_spread":0.2801808557924655,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2807496383","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9781019,0.017158376,0.0000014215642,0.0026545536,0.00009117219,0.0014521386,0.0000027416588,0.00005846907,0.00047921372],"genre_scores_gemma":[0.99062264,0.007144354,0.00074586016,0.0011896245,0.000028559733,0.00008509151,0.000013749617,0.00002572925,0.00014437754],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99870735,0.0001060624,0.0004116641,0.00035282125,0.00018630666,0.00023578771],"domain_scores_gemma":[0.99901086,0.00013595948,0.00017726532,0.00036700626,0.00020289098,0.0001060129],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029388416,0.0001917126,0.00059719494,0.000059314614,0.00007937629,0.000009024086,0.00006125799,0.00008013375,0.00013635772],"category_scores_gemma":[0.00003908937,0.000115337,0.000099079065,0.0003268571,0.0004280303,0.000059004007,0.00003531699,0.00014732411,0.0000055190394],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0045801094,0.0022754432,0.8991045,0.0033323218,0.0011966727,0.01888268,0.0004712362,0.000002652063,0.0065080198,0.00012577491,0.0011120612,0.06240855],"study_design_scores_gemma":[0.058331955,0.059490055,0.8583467,0.0072414936,0.0027522938,0.0036196245,0.0005897332,0.0007097341,0.0031353312,0.0007938981,0.0037676925,0.0012214901],"about_ca_topic_score_codex":0.0000029455955,"about_ca_topic_score_gemma":0.0000013624091,"teacher_disagreement_score":0.061187062,"about_ca_system_score_codex":0.000007575403,"about_ca_system_score_gemma":0.000019104058,"threshold_uncertainty_score":0.47033066},"labels":[],"label_agreement":null},{"id":"W2899457817","doi":"10.1007/s13300-018-0524-z","title":"Liraglutide and Glycaemic Outcomes in the LEADER Trial","year":2018,"lang":"en","type":"article","venue":"Diabetes Therapy","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Lunenfeld-Tanenbaum Research Institute","funders":"Novo Nordisk","keywords":"Liraglutide; Medicine; Diabetes mellitus; Intensive care medicine; Empagliflozin; Internal medicine; Type 2 diabetes; Endocrinology","score_opus":0.031761159776296614,"score_gpt":0.2979267338069327,"score_spread":0.26616557403063607,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2899457817","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99053025,0.0008653353,0.0000011604261,0.00388916,0.00018259749,0.0009066134,0.0000014307428,0.000038426337,0.0035850033],"genre_scores_gemma":[0.9920018,0.00021583131,0.00007804623,0.006272835,0.00024534314,0.00011107558,0.000008644144,0.000015066623,0.0010514077],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991868,0.000048893267,0.0001507486,0.0001842624,0.00015758834,0.00027167838],"domain_scores_gemma":[0.99952495,0.00011235374,0.00003347538,0.00027313564,0.000018321312,0.00003777347],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025821765,0.00013778146,0.00024816176,0.00008703854,0.00005070081,0.0000335411,0.000094663155,0.00004300754,0.000093167066],"category_scores_gemma":[0.000024675108,0.000075827105,0.00006368321,0.00012840964,0.00013148984,0.00005853167,0.000019537865,0.00007762419,0.00005315642],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003015542,0.0009346011,0.83348584,0.000024191011,0.00045006178,0.000012435,0.0023028504,7.910523e-8,0.0014301923,0.00088162854,0.0048044017,0.15265816],"study_design_scores_gemma":[0.10815044,0.0057859737,0.7875007,0.00006608874,0.00013754309,9.555135e-7,0.00041858558,0.00004996944,0.004022895,0.0013923178,0.09217886,0.00029567367],"about_ca_topic_score_codex":0.000008391126,"about_ca_topic_score_gemma":0.000008986557,"teacher_disagreement_score":0.1523625,"about_ca_system_score_codex":0.000018444816,"about_ca_system_score_gemma":0.000010850319,"threshold_uncertainty_score":0.30921397},"labels":[],"label_agreement":null},{"id":"W2904126392","doi":"10.1007/s13300-018-0553-7","title":"Investigating the Association Between Baseline Characteristics (HbA1c and Body Mass Index) and Clinical Outcomes of Fast-Acting Insulin Aspart in People with Diabetes: A Post Hoc Analysis","year":2018,"lang":"en","type":"article","venue":"Diabetes Therapy","topic":"Diabetes, Cardiovascular Risks, and Lipoproteins","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Western University; University of Alberta","funders":"Novo Nordisk","keywords":"Insulin aspart; Medicine; Post-hoc analysis; Body mass index; Type 2 diabetes; Internal medicine; Diabetes mellitus; Insulin; Type 1 diabetes; Endocrinology","score_opus":0.015776097888142365,"score_gpt":0.27625360368562524,"score_spread":0.26047750579748286,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2904126392","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979166,0.00061543705,0.00007302755,0.0005906145,0.00006242768,0.0005918408,0.00006908402,0.00003994893,0.000041018364],"genre_scores_gemma":[0.99765694,0.00034509657,0.00058843545,0.00079467834,0.00038990364,0.00004014846,0.00011855772,0.00004239881,0.000023819],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973398,0.00046874286,0.0008108002,0.00043567922,0.0004950937,0.000449927],"domain_scores_gemma":[0.997228,0.0011916592,0.00058435544,0.0004601974,0.00036499128,0.00017075884],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033541333,0.00029398524,0.0015112233,0.00027583473,0.00012927219,0.000077849065,0.000119073586,0.00020928126,0.00001558984],"category_scores_gemma":[0.0014526114,0.00019299373,0.0002792342,0.00084088166,0.0002939848,0.00015298823,0.00005559388,0.00041220657,0.0000021040578],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003630561,0.00007072339,0.86008126,0.000044593915,0.003950312,6.119537e-7,0.00056402973,9.127961e-7,0.0002631066,0.0000013173676,0.0000041238427,0.13498269],"study_design_scores_gemma":[0.002685832,0.0010002869,0.9920315,0.00013031714,0.0012771194,1.1984899e-7,0.0002681844,0.0015265665,0.00061807985,0.000020447254,0.00022353826,0.00021796899],"about_ca_topic_score_codex":0.00039567694,"about_ca_topic_score_gemma":0.0004847035,"teacher_disagreement_score":0.13476472,"about_ca_system_score_codex":0.000057033227,"about_ca_system_score_gemma":0.000082635335,"threshold_uncertainty_score":0.78700554},"labels":[],"label_agreement":null},{"id":"W2914739803","doi":"10.1007/s13300-019-0568-8","title":"Rates of Hypoglycemia Predicted in Patients with Type 2 Diabetes on Insulin Glargine 300 U/ml Versus First- and Second-Generation Basal Insulin Analogs: The Real-World LIGHTNING Study","year":2019,"lang":"en","type":"article","venue":"Diabetes Therapy","topic":"Diabetes Management and Research","field":"Medicine","cited_by":65,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lawson Health Research Institute; Western University","funders":"Sanofi","keywords":"Medicine; Insulin glargine; Insulin degludec; Insulin detemir; Hypoglycemia; Insulin; Type 2 diabetes; Diabetes mellitus; Internal medicine; Basal (medicine); Basal insulin; Endocrinology","score_opus":0.021182174102583346,"score_gpt":0.2726222910436291,"score_spread":0.2514401169410458,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2914739803","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99603486,0.0004901947,1.0319534e-7,0.00023209673,0.0002297645,0.0020173222,0.000017322314,0.00003669781,0.0009416316],"genre_scores_gemma":[0.99878657,0.00019776086,0.000027256476,0.00021367962,0.00010911695,0.00006772899,0.00020591854,0.000046242167,0.0003457386],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99807966,0.00017385192,0.0003744535,0.00041813843,0.0005219731,0.00043192998],"domain_scores_gemma":[0.9987173,0.00036872955,0.00015436584,0.00047035093,0.00020480773,0.000084435436],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00054414984,0.0002678295,0.00049138337,0.00042678113,0.000089478744,0.000054519587,0.00019054036,0.00007805093,0.0002485178],"category_scores_gemma":[0.00007724142,0.00016366578,0.000043174157,0.0009574551,0.00010435036,0.00015531434,0.000071151204,0.00031301778,0.000014747293],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002210964,0.0010205061,0.9870757,0.00007856529,0.00042117,0.0000013089447,0.0004983681,0.000077380886,0.0009683419,0.000024028257,0.00022856101,0.0073950975],"study_design_scores_gemma":[0.017064532,0.009466986,0.9676042,0.00015256091,0.00004565205,3.715653e-9,0.00010649116,0.001996803,0.0028496375,0.000016613938,0.0005157106,0.00018077409],"about_ca_topic_score_codex":0.000019556952,"about_ca_topic_score_gemma":0.00020089585,"teacher_disagreement_score":0.019471474,"about_ca_system_score_codex":0.000062080355,"about_ca_system_score_gemma":0.00004819792,"threshold_uncertainty_score":0.6674097},"labels":[],"label_agreement":null},{"id":"W2924791861","doi":"10.1007/s13300-019-0594-6","title":"Downregulation of T-Cell Transcription Factors in Adult Latent Autoimmune Diabetes with High-Titer Glutamic Acid Decaroxylase Antibody","year":2019,"lang":"en","type":"article","venue":"Diabetes Therapy","topic":"Diabetes and associated disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ministry of Education and Child Care","funders":"National Key Research and Development Program of China","keywords":"FOXP3; GATA3; RAR-related orphan receptor gamma; Medicine; Immunology; Peripheral blood mononuclear cell; Titer; Antibody; T cell; Internal medicine; T helper cell; Endocrinology; Diabetes mellitus; Flow cytometry; Transcription factor; Immune system; Biology; Biochemistry; In vitro","score_opus":0.003260832056153989,"score_gpt":0.19534842275032294,"score_spread":0.19208759069416895,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2924791861","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982299,0.0010698478,0.0000129057225,0.000051959643,0.00010466218,0.00039150807,0.000039856197,0.000019837027,0.00007951277],"genre_scores_gemma":[0.99824816,0.000417827,0.00007252972,0.00014419731,0.000020953361,0.00002013961,0.00092900987,0.000042165695,0.00010501106],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998712,0.000075236545,0.00029064342,0.00035259288,0.00017323911,0.00039631082],"domain_scores_gemma":[0.9993659,0.000015048842,0.00016533353,0.00031310125,0.000096149,0.00004446098],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012367767,0.00025212232,0.00031730562,0.00010655304,0.00002940261,0.00002401667,0.00016967554,0.00018926148,0.000048694408],"category_scores_gemma":[0.000006740547,0.00020374237,0.0001268953,0.00019733362,0.00005925729,0.000020016703,0.000018169507,0.00009294693,0.0000075197368],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003846686,0.00016034584,0.39947525,0.00002362907,0.000061915474,8.943122e-8,0.00008332341,0.0002066853,0.59909624,0.000009370468,0.000007005391,0.00083765644],"study_design_scores_gemma":[0.001916722,0.00050582364,0.38444686,0.00004104787,0.000011176063,1.4944677e-8,0.000045115878,0.00015907455,0.6125468,0.000029106594,0.0001075687,0.00019070494],"about_ca_topic_score_codex":0.000030638927,"about_ca_topic_score_gemma":0.000015564277,"teacher_disagreement_score":0.015028383,"about_ca_system_score_codex":0.000020246836,"about_ca_system_score_gemma":0.000031249354,"threshold_uncertainty_score":0.83083725},"labels":[],"label_agreement":null},{"id":"W2942132427","doi":"10.1007/s13300-019-0615-5","title":"GLP-1 RA Treatment and Dosing Patterns Among Type 2 Diabetes Patients in Six Countries: A Retrospective Analysis of Pharmacy Claims Data","year":2019,"lang":"en","type":"article","venue":"Diabetes Therapy","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Eli Lilly and Company","keywords":"Medicine; Discontinuation; Exenatide; Type 2 diabetes; Liraglutide; Dulaglutide; Internal medicine; Retrospective cohort study; Dosing; Lira; Pharmacy; Diabetes mellitus; Family medicine; Endocrinology","score_opus":0.01924185101910407,"score_gpt":0.28805187489398093,"score_spread":0.26881002387487685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2942132427","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968725,0.0012894694,7.6081716e-7,0.000063357904,0.00015056084,0.0011596404,0.00022006086,0.00003748647,0.00020619945],"genre_scores_gemma":[0.9942459,0.003907828,0.00003527272,0.00022937528,0.000031972806,0.000042049778,0.001330721,0.00003389147,0.00014300182],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983281,0.000060077964,0.0003625784,0.0005699912,0.00026731673,0.00041194112],"domain_scores_gemma":[0.99872327,0.00011994043,0.00018272948,0.00077255594,0.000104453,0.00009703264],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019521713,0.0002971935,0.0008616305,0.00048532514,0.000034746747,0.000042614713,0.00017235414,0.000056783116,0.0003116853],"category_scores_gemma":[0.0000124378075,0.0002308688,0.00011484459,0.0007182014,0.00007822416,0.00027202143,0.000081178565,0.0000707691,0.00001029017],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011695962,0.0009436613,0.97901726,0.00006742062,0.0040298323,0.0000017911166,0.00058456766,0.0000075312273,0.00041645326,0.000011175548,0.000045443838,0.014757892],"study_design_scores_gemma":[0.0073962435,0.0014576721,0.98148036,0.000108396096,0.0013820443,8.9392005e-9,0.00006605699,0.0030206614,0.00317504,0.000014686316,0.001696768,0.00020209019],"about_ca_topic_score_codex":0.00015655691,"about_ca_topic_score_gemma":0.00011835082,"teacher_disagreement_score":0.014555802,"about_ca_system_score_codex":0.0002081419,"about_ca_system_score_gemma":0.00002467389,"threshold_uncertainty_score":0.94145566},"labels":[],"label_agreement":null},{"id":"W2973028609","doi":"10.1007/s13300-019-00687-y","title":"Family Members: The Forgotten Players in the Diabetes Care Team (The TALK-HYPO Study)","year":2019,"lang":"en","type":"article","venue":"Diabetes Therapy","topic":"Diabetes Management and Education","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Novo Nordisk","keywords":"Hypoglycemia; Medicine; Diabetes mellitus; Type 1 diabetes; Family medicine; Type 2 diabetes; Health care; Pediatrics; Nursing; Endocrinology","score_opus":0.014958111875017766,"score_gpt":0.2623535770906601,"score_spread":0.24739546521564232,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2973028609","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9809435,0.0024636637,1.6806432e-7,0.0034040294,0.00060883875,0.0033031933,0.0000048461247,0.00006174602,0.009210014],"genre_scores_gemma":[0.9888964,0.000115234965,0.000011181271,0.009349181,0.00030606097,0.0005052739,0.000052979638,0.000039952316,0.00072370924],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99794495,0.00024892096,0.00031309444,0.00036280238,0.0005314265,0.00059880316],"domain_scores_gemma":[0.99818385,0.0004846154,0.0001224772,0.0010759414,0.000082492865,0.00005060764],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001059822,0.0002870332,0.0003426916,0.00012934218,0.00020001867,0.00015608374,0.00072346587,0.00007076148,0.00016307895],"category_scores_gemma":[0.0000500856,0.0001326744,0.00016916831,0.0006161112,0.000114091694,0.0001782662,0.000064615815,0.0003587983,0.0003134014],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000029561843,0.00039397422,0.9312168,0.00004511067,0.00025041125,8.80187e-7,0.017822769,0.000022833156,0.0010899993,0.00006124253,0.009679449,0.039386984],"study_design_scores_gemma":[0.0022629302,0.00089273666,0.8261446,0.00006606237,0.00012545109,1.3671391e-7,0.07914561,0.00024270354,0.0005931311,0.00015647316,0.09013497,0.0002352428],"about_ca_topic_score_codex":0.00005614437,"about_ca_topic_score_gemma":0.000031213614,"teacher_disagreement_score":0.10507222,"about_ca_system_score_codex":0.00007737358,"about_ca_system_score_gemma":0.000047853202,"threshold_uncertainty_score":0.54103047},"labels":[],"label_agreement":null},{"id":"W2982342400","doi":"10.1007/s13300-019-00715-x","title":"Glomerular Filtration Rate and Associated Risks ofCardiovascular Events, Mortality, and Severe Hypoglycemia in Patients with Type 2 Diabetes:Secondary Analysis (DEVOTE 11)","year":2019,"lang":"en","type":"article","venue":"Diabetes Therapy","topic":"Chronic Kidney Disease and Diabetes","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; University of Toronto","funders":"National Center for Advancing Translational Sciences; National Institute of Diabetes and Digestive and Kidney Diseases; Janssen Research and Development; National Institutes of Health; Novo Nordisk; European Association for the Study of Diabetes; Zafgen; Eli Lilly and Company; AstraZeneca; CSL Behring; Merck Sharp and Dohme; Eisai; Sanofi; MannKind Corporation; GlaxoSmithKline; Pfizer","keywords":"Medicine; Hypoglycemia; Diabetes mellitus; Renal function; Type 2 diabetes; Type 1 diabetes; Intensive care medicine; Internal medicine; Endocrinology","score_opus":0.011898879180850336,"score_gpt":0.2452931604264202,"score_spread":0.23339428124556985,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2982342400","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99326724,0.005538098,6.83654e-7,0.000051408177,0.00006836945,0.000778188,0.00009959121,0.000044778273,0.00015164056],"genre_scores_gemma":[0.9975224,0.0005361963,0.000023328257,0.0006760562,0.000031875014,0.00002554047,0.0010682289,0.00003726997,0.00007906715],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981243,0.00019043656,0.0003194766,0.0005353741,0.00037610676,0.0004543063],"domain_scores_gemma":[0.99888605,0.000110590634,0.00013993736,0.00047664368,0.00015111465,0.00023566493],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00045176473,0.00030587352,0.0008266606,0.00025229584,0.000059674112,0.000044717843,0.00007695376,0.00016603386,0.00030601086],"category_scores_gemma":[0.000081742706,0.0002524368,0.00018080669,0.0007425714,0.00007013193,0.00020210643,0.00003793388,0.00020292497,0.000014050698],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001277759,0.00023544629,0.99132866,0.00009445235,0.003992248,0.0000026540386,0.000070035974,0.00004176027,0.00042924672,0.0000024379112,0.00006427259,0.0036109863],"study_design_scores_gemma":[0.00976236,0.00056056044,0.9865193,0.000121272176,0.001191862,9.1669406e-8,0.0000199282,0.00061867357,0.0005532741,0.000090437854,0.00024186065,0.00032041807],"about_ca_topic_score_codex":0.00007898965,"about_ca_topic_score_gemma":0.000040339495,"teacher_disagreement_score":0.009634584,"about_ca_system_score_codex":0.00010265036,"about_ca_system_score_gemma":0.00013634095,"threshold_uncertainty_score":0.9999928},"labels":[],"label_agreement":null},{"id":"W2982524000","doi":"10.1007/s13300-019-00716-w","title":"The Association Between Phosphorylated Neurofilament Heavy Chain (pNF-H) and Small Fiber Neuropathy (SFN) in Patients with Impaired Glucose Tolerance","year":2019,"lang":"en","type":"article","venue":"Diabetes Therapy","topic":"Pain Mechanisms and Treatments","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Tianjin Medical University; Natural Science Foundation of Tianjin City","keywords":"Medicine; Impaired glucose tolerance; Diabetes mellitus; Diabetic neuropathy; Internal medicine; Phosphorylation; Neurofilament; Endocrinology; Type 2 diabetes; Biochemistry; Immunohistochemistry; Biology","score_opus":0.005446343467524524,"score_gpt":0.1910564402811468,"score_spread":0.18561009681362228,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2982524000","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99756575,0.000751318,0.0000010194834,0.00032009694,0.00009363334,0.0011489319,0.000012357929,0.000041169853,0.00006571824],"genre_scores_gemma":[0.9985108,0.00024987315,0.000057360783,0.0006353165,0.000029468807,0.000047833804,0.000053099826,0.00003719144,0.0003790891],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998717,0.00013815402,0.00021148425,0.000295239,0.00026076424,0.00037734825],"domain_scores_gemma":[0.99924684,0.00019104432,0.0001380272,0.0002700181,0.00006860015,0.00008546854],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031540045,0.00020164537,0.00031142132,0.000046503836,0.00008331357,0.000040143186,0.00007247415,0.000074738826,0.00001985924],"category_scores_gemma":[0.000022891943,0.00012521056,0.00004484403,0.00017393862,0.000018895913,0.000057318306,0.000019604438,0.00016022782,0.000029729174],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034865917,0.00020229883,0.9619556,0.000009322451,0.00012071246,0.0000027033384,0.0001795689,0.0000034629259,0.0007195185,0.00000607323,0.000011085548,0.036440983],"study_design_scores_gemma":[0.007204718,0.0017879158,0.9827189,0.00006463689,0.00002826085,9.224739e-8,0.000010370653,0.00016347264,0.007072773,0.000044810597,0.0007754655,0.00012861984],"about_ca_topic_score_codex":0.0000199859,"about_ca_topic_score_gemma":0.0000041350586,"teacher_disagreement_score":0.036312364,"about_ca_system_score_codex":0.000114593204,"about_ca_system_score_gemma":0.000023758008,"threshold_uncertainty_score":0.51059383},"labels":[],"label_agreement":null},{"id":"W3000373527","doi":"10.1007/s13300-019-00749-1","title":"Impact of Switching from Twice-Daily Basal Insulin to Once-Daily Insulin Glargine 300 U/mL in People with Type 1 Diabetes on Basal–Bolus Insulin: Phase 4 OPTIMIZE Study","year":2020,"lang":"en","type":"article","venue":"Diabetes Therapy","topic":"Diabetes Management and Research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"Universitaire Ziekenhuizen Leuven, KU Leuven; Sanofi","keywords":"Insulin glargine; Medicine; Basal insulin; Insulin; Basal (medicine); Diabetes mellitus; Internal medicine; Endocrinology; Type 2 diabetes","score_opus":0.03087325850078365,"score_gpt":0.32439062941125585,"score_spread":0.2935173709104722,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3000373527","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99173415,0.001842046,0.000028645754,0.0023359968,0.00017463646,0.0031894213,0.00011151161,0.00017383783,0.00040973202],"genre_scores_gemma":[0.9943711,0.00034857276,0.0008338204,0.0033432236,0.00043886265,0.00018064398,0.0002190203,0.00019147008,0.00007328888],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99505556,0.0003928571,0.0009436002,0.0011384522,0.0012379733,0.0012315586],"domain_scores_gemma":[0.9970775,0.00060602406,0.00029166407,0.000952003,0.00033876367,0.0007340112],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00086058344,0.00076809985,0.001699733,0.00072255306,0.00011907962,0.00014116705,0.00073581346,0.0002003389,0.00071794214],"category_scores_gemma":[0.00046448185,0.00056920963,0.00028128832,0.0027892205,0.00009528662,0.0003231595,0.00025155226,0.00093654345,0.0001644496],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014258306,0.009691505,0.8324911,0.00015830755,0.002135685,0.0000893853,0.008053785,0.0024819213,0.040143006,0.000005137451,0.0015842953,0.088907585],"study_design_scores_gemma":[0.052762363,0.050812375,0.86739814,0.00060532766,0.00020356038,8.758349e-8,0.0010460634,0.01579919,0.009614495,0.00006862951,0.0006685778,0.0010211898],"about_ca_topic_score_codex":0.00028654494,"about_ca_topic_score_gemma":0.000053882493,"teacher_disagreement_score":0.08788639,"about_ca_system_score_codex":0.00021975172,"about_ca_system_score_gemma":0.00032370404,"threshold_uncertainty_score":0.9996759},"labels":[],"label_agreement":null},{"id":"W3008199068","doi":"10.1007/s13300-020-00775-4","title":"Development and Validation of a New Diabetes Risk Score in Guyana","year":2020,"lang":"en","type":"article","venue":"Diabetes Therapy","topic":"Diabetes, Cardiovascular Risks, and Lipoproteins","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; University of Toronto","funders":"Medical Research Council; Banting and Best Diabetes Centre, University of Toronto; World Diabetes Foundation; University of Toronto","keywords":"Medicine; Diabetes mellitus; Framingham Risk Score; Cohort; Population; Demography; Pandemic; Environmental health; Gerontology; Disease; Internal medicine; Coronavirus disease 2019 (COVID-19); Endocrinology","score_opus":0.031073245118525494,"score_gpt":0.2411962630718062,"score_spread":0.2101230179532807,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3008199068","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99022526,0.0084868325,0.00003408358,0.00042237222,0.000048655347,0.0005657461,0.0000066071498,0.00005242983,0.00015802193],"genre_scores_gemma":[0.99544406,0.0008061351,0.0027493811,0.0006981462,0.00016443557,0.000036091547,0.00003940225,0.000035258407,0.000027078378],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99865377,0.000071948845,0.0003580857,0.00031766045,0.00029807285,0.00030048485],"domain_scores_gemma":[0.999322,0.000051153307,0.00011905282,0.00024160898,0.000051589737,0.00021458993],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037270467,0.00019424454,0.00059003395,0.00011982953,0.00003560185,0.000020738302,0.00009178208,0.00009160172,0.000057503064],"category_scores_gemma":[0.00013636223,0.00016917895,0.00013905496,0.00032922355,0.000057646746,0.0000971387,0.00003319474,0.00016577315,0.000013051151],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000036360147,0.00005771757,0.37530634,0.00009615214,0.0002710488,0.0000016640276,0.0020449802,0.000009650576,0.0037486635,0.0000065563145,0.00013251713,0.61828834],"study_design_scores_gemma":[0.003478841,0.00034066293,0.58826387,0.00017423788,0.00006746326,1.8771499e-7,0.000113749506,0.00014362401,0.38787794,0.00014802598,0.01917665,0.00021472063],"about_ca_topic_score_codex":0.00018361022,"about_ca_topic_score_gemma":0.000023410432,"teacher_disagreement_score":0.61807364,"about_ca_system_score_codex":0.000026440497,"about_ca_system_score_gemma":0.00011441342,"threshold_uncertainty_score":0.68989176},"labels":[],"label_agreement":null},{"id":"W3010968620","doi":"10.1007/s13300-020-00797-y","title":"Fixed-Ratio Combination of Insulin and GLP-1 RA in Patients with Longstanding Type 2 Diabetes: A Subanalysis of LixiLan-L","year":2020,"lang":"en","type":"article","venue":"Diabetes Therapy","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Manitoba Beekeepers' Association","funders":"Sanofi","keywords":"Lixisenatide; Medicine; Insulin glargine; Type 2 diabetes; Internal medicine; Glycated hemoglobin; Endocrinology; Diabetes mellitus; Insulin; Quartile; Gastroenterology; Gastric emptying; Exenatide; Insulin degludec; Confidence interval","score_opus":0.01154119011127701,"score_gpt":0.22026403721401855,"score_spread":0.20872284710274153,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3010968620","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99788296,0.0010860263,0.000011044533,0.00028828415,0.000020510219,0.0005230636,0.000009855353,0.0000192147,0.00015901675],"genre_scores_gemma":[0.9990671,0.00021726772,0.00019688105,0.0003100437,0.000011797618,0.000017839386,0.00014269465,0.000019278446,0.000017083368],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99905646,0.000037406324,0.00028570276,0.00020572454,0.00023697272,0.00017772726],"domain_scores_gemma":[0.99942935,0.00005911523,0.00016392015,0.00015487534,0.0001274232,0.00006533888],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011283647,0.00014831858,0.00047160688,0.00017664215,0.000020339534,0.000014539622,0.00005938426,0.00004545191,0.00003702517],"category_scores_gemma":[0.000038205002,0.00011423983,0.000047898415,0.0005637714,0.00007438404,0.00010485272,0.000022778859,0.000059475246,0.0000015704342],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027522794,0.0005128957,0.9783879,0.00015312743,0.00043235018,7.4733526e-7,0.00078727974,0.000008168702,0.0020488352,0.00008069118,0.000042477113,0.017270321],"study_design_scores_gemma":[0.008958949,0.003970402,0.96566486,0.00017278524,0.0001891557,6.423949e-9,0.0000907337,0.001007457,0.019591698,0.000052026568,0.00016002462,0.0001419089],"about_ca_topic_score_codex":0.0000068316917,"about_ca_topic_score_gemma":0.0000037142004,"teacher_disagreement_score":0.017542863,"about_ca_system_score_codex":0.000031709293,"about_ca_system_score_gemma":0.000021289885,"threshold_uncertainty_score":0.46585652},"labels":[],"label_agreement":null},{"id":"W3015457795","doi":"10.1007/s13300-020-00802-4","title":"Systemic Delivery of siRNA Specific for Silencing TLR4 Gene Expression Reduces Diabetic Cardiomyopathy in a Mouse Model of Streptozotocin-Induced Type 1 Diabetes","year":2020,"lang":"en","type":"article","venue":"Diabetes Therapy","topic":"Cardiac Fibrosis and Remodeling","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"National Natural Science Foundation of China","keywords":"Diabetic cardiomyopathy; Streptozotocin; Gene silencing; Medicine; Diabetes mellitus; TLR4; Type 2 diabetes; Gene; Cardiomyopathy; Gene expression; Bioinformatics; Internal medicine; Endocrinology; Genetics; Heart failure; Biology; Receptor","score_opus":0.04397344159512325,"score_gpt":0.25412198887767756,"score_spread":0.2101485472825543,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3015457795","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9882012,0.0099968845,0.00007852131,0.000061052575,0.00015112107,0.0013442895,0.00009380252,0.00004928521,0.000023832812],"genre_scores_gemma":[0.996281,0.0013851956,0.0017951622,0.000107306274,0.000217931,0.000085786975,0.00004095398,0.00007788637,0.0000087363],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99788344,0.000085652086,0.00076545787,0.00047913424,0.00035913338,0.00042718876],"domain_scores_gemma":[0.99866563,0.00017346788,0.00029279393,0.00040559453,0.00030975277,0.00015275713],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003629812,0.00029269914,0.0011767455,0.00019218148,0.000043053817,0.0000145408085,0.00017244722,0.0001820221,0.000007439337],"category_scores_gemma":[0.00006878355,0.0002450371,0.00043975978,0.0003204981,0.000055489327,0.000104457766,0.00005281607,0.0001784979,0.0000014497547],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002788369,0.000100657046,0.02004494,0.0005644374,0.00012339558,3.9478732e-7,0.0014585244,0.006865591,0.96580124,0.000002831568,0.000043759057,0.0047154],"study_design_scores_gemma":[0.002083643,0.0006593755,0.00096251135,0.0008630604,0.000053632553,2.1577797e-7,0.00033685498,0.043277457,0.9515096,0.000023707977,0.0000053636945,0.00022457563],"about_ca_topic_score_codex":0.0000060475986,"about_ca_topic_score_gemma":1.4998996e-7,"teacher_disagreement_score":0.036411867,"about_ca_system_score_codex":0.000070292124,"about_ca_system_score_gemma":0.00012670689,"threshold_uncertainty_score":0.99923235},"labels":[],"label_agreement":null},{"id":"W3016314642","doi":"10.1007/s13300-020-00818-w","title":"Recreational Cannabis Usage Among Young Adults Living with Diabetes: Protocol for a Mixed Methods Study","year":2020,"lang":"en","type":"article","venue":"Diabetes Therapy","topic":"Cannabis and Cannabinoid Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Impact; Population Health Research Institute; Hamilton Health Sciences; University of Toronto; Toronto Metropolitan University; SickKids Foundation; Hospital for Sick Children; McMaster University; Women's College Hospital","funders":"","keywords":"Medicine; Diabetes mellitus; Cannabis; Recreation; Gerontology; Protocol (science); Recreational Drug; Psychiatry; Environmental health; Alternative medicine; Endocrinology; Ecology; Pathology","score_opus":0.03044083539171841,"score_gpt":0.36507724351955895,"score_spread":0.3346364081278405,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3016314642","genre_codex":"empirical","genre_gemma":"protocol","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.840582,0.00007587995,0.00031695853,0.0038283796,0.000044259577,0.15474504,0.000027297523,0.00013909534,0.00024104498],"genre_scores_gemma":[0.28258333,0.0000036606764,0.0038213595,0.0016043419,0.000516564,0.7094528,0.000036330155,0.00013730282,0.0018443211],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972291,0.00037805998,0.00040498123,0.0006766888,0.000604973,0.0007061873],"domain_scores_gemma":[0.9983038,0.00012929636,0.00015058488,0.00039915607,0.00046525802,0.00055192003],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011493901,0.0003436744,0.0006004833,0.00014054115,0.00022730899,0.000114473005,0.00024019845,0.00010657116,0.00037374272],"category_scores_gemma":[0.0006158758,0.00024680438,0.00019273501,0.00057818677,0.00015498517,0.00016187348,0.00006420152,0.0003058431,0.000004573844],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011414597,0.0010202447,0.88283974,0.0005124516,0.00049696607,0.000006544704,0.0049691177,0.000009313945,0.005838761,0.00001021459,0.029757114,0.073398046],"study_design_scores_gemma":[0.012170988,0.013082367,0.9097411,0.00050867716,0.00007815247,9.2990297e-7,0.0024946646,0.0035427446,0.011399924,0.000025932952,0.04642024,0.00053425395],"about_ca_topic_score_codex":0.000062979925,"about_ca_topic_score_gemma":0.000054626635,"teacher_disagreement_score":0.5579987,"about_ca_system_score_codex":0.00010829772,"about_ca_system_score_gemma":0.00034245345,"threshold_uncertainty_score":0.99999845},"labels":[],"label_agreement":null},{"id":"W3019736633","doi":"10.1007/s13300-020-00812-2","title":"Latest Evidence on Sulfonylureas: What’s New?","year":2020,"lang":"en","type":"review","venue":"Diabetes Therapy","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Servier","keywords":"Medicine; Diabetes mellitus; Type 2 Diabetes Mellitus; Type 2 diabetes; Clinical trial; Intensive care medicine; Internal medicine; Endocrinology","score_opus":0.11721029630246166,"score_gpt":0.35704289838259157,"score_spread":0.2398326020801299,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3019736633","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000626013,0.99306655,8.735568e-7,0.002267982,0.0006903049,0.0024378384,0.000010100462,0.00027775604,0.0011859763],"genre_scores_gemma":[0.000018691328,0.99020296,0.000110475674,0.0031969934,0.0009453527,0.00030597477,0.0002886129,0.00016817646,0.0047627664],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99744886,0.00011811627,0.0005467724,0.0008294772,0.00046111704,0.00059567037],"domain_scores_gemma":[0.9978832,0.00044408586,0.00028374762,0.00091277313,0.00004634477,0.00042982664],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00018029733,0.000832376,0.002526263,0.00025386634,0.000060812556,0.0002476013,0.00039233296,0.00028265448,0.00048335711],"category_scores_gemma":[0.000091173395,0.0005781882,0.0009393376,0.00053294987,0.0000555728,0.00030201997,0.000080963284,0.00043424222,0.0022485992],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000024634897,0.00020387798,0.00007462954,0.0035273528,0.0014177327,0.00005701405,0.000047998517,6.23175e-8,0.0000017367385,0.00010599466,0.022472883,0.9720661],"study_design_scores_gemma":[0.000828851,0.0014586087,0.00004107516,0.047273178,0.0014003629,0.000001217965,0.000007541276,0.0000015732126,0.00002795198,0.000048806018,0.94846654,0.0004442935],"about_ca_topic_score_codex":0.0000044673393,"about_ca_topic_score_gemma":6.3047366e-7,"teacher_disagreement_score":0.9716218,"about_ca_system_score_codex":0.00021276841,"about_ca_system_score_gemma":0.00030792755,"threshold_uncertainty_score":0.9996669},"labels":[],"label_agreement":null},{"id":"W3034312489","doi":"10.1007/s13300-020-00851-9","title":"The Effectiveness of Acceptance and Commitment Therapy on Pain Acceptance and Pain Perception in Patients with Painful Diabetic Neuropathy: A Randomized Controlled Trial","year":2020,"lang":"en","type":"article","venue":"Diabetes Therapy","topic":"Pain Mechanisms and Treatments","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Deputy for Research and Technology, Kermanshah University of Medical Sciences; Kermanshah University of Medical Sciences; Bausch Health; Ortho Dermatologics","keywords":"Acceptance and commitment therapy; Medicine; Physical therapy; Neuropathic pain; Randomized controlled trial; Intervention (counseling); McGill Pain Questionnaire; Clinical trial; Chronic pain; Diabetic neuropathy; Test (biology); Diabetes mellitus; Psychiatry; Surgery; Anesthesia; Internal medicine; Visual analogue scale","score_opus":0.008025394181544177,"score_gpt":0.22792429264848021,"score_spread":0.21989889846693603,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3034312489","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98809516,0.0015496211,0.00013293781,0.00038446917,0.000055917964,0.0097267525,0.000005401858,0.000027791235,0.000021965567],"genre_scores_gemma":[0.9952896,0.0013966085,0.00006400225,0.0017929435,0.000039059407,0.0013621338,0.000016175236,0.000034905337,0.0000045298502],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99290895,0.0057381247,0.00040242085,0.00036040487,0.0003164865,0.00027358424],"domain_scores_gemma":[0.99361724,0.0057436908,0.00021858902,0.00023771248,0.000075942524,0.00010681912],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0056964816,0.0003027597,0.0013206003,0.000058978112,0.00010230692,0.000038533068,0.00008747275,0.00006958184,0.00001433868],"category_scores_gemma":[0.0007743102,0.00015539836,0.00014278608,0.00016055578,0.00017305557,0.00005993504,0.000014152451,0.00015480936,6.752626e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.71634007,0.00053723325,0.20006219,0.000039628307,0.00032010788,0.0000020315624,0.00041558375,0.00000288188,0.0009683317,0.00004197951,0.0000028152092,0.081267156],"study_design_scores_gemma":[0.69427246,0.008546488,0.29521367,0.00014837777,0.000042091764,3.316552e-8,0.000042828284,0.001026944,0.00040333514,0.00017418781,0.0000149743755,0.00011462816],"about_ca_topic_score_codex":0.0000036124163,"about_ca_topic_score_gemma":0.000001318231,"teacher_disagreement_score":0.09515149,"about_ca_system_score_codex":0.000036978363,"about_ca_system_score_gemma":0.000025558524,"threshold_uncertainty_score":0.63369614},"labels":[],"label_agreement":null},{"id":"W3038415136","doi":"10.1007/s13300-020-00869-z","title":"Evaluation of Characteristics of Gastrointestinal Adverse Events with Once-Weekly Dulaglutide Treatment in Chinese Patients with Type 2 Diabetes: A Post Hoc Pooled Analysis of Two Randomized Trials","year":2020,"lang":"en","type":"article","venue":"Diabetes Therapy","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ministry of Education and Child Care","funders":"Eli Lilly and Company","keywords":"Medicine; Dulaglutide; Post-hoc analysis; Type 2 diabetes; Diabetes mellitus; Adverse effect; Internal medicine; Randomized controlled trial; Pooled analysis; Post hoc; Traditional medicine; Exenatide; Meta-analysis; Endocrinology","score_opus":0.02863615751985996,"score_gpt":0.30221426936298373,"score_spread":0.27357811184312375,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3038415136","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960622,0.00032558004,0.000017439916,0.00011336173,0.000027868835,0.0032418147,0.00013861971,0.000018283605,0.00005482827],"genre_scores_gemma":[0.9977579,0.00009084688,0.00092763297,0.000115679584,0.000023882616,0.00017114221,0.00086912443,0.000031874297,0.00001188418],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966291,0.00074805046,0.0010839875,0.00034014106,0.00091170846,0.00028696956],"domain_scores_gemma":[0.9967966,0.00054098514,0.001149969,0.00035249427,0.001040828,0.00011909453],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016463343,0.00035916612,0.0029399346,0.0004685349,0.00001684022,0.0000041115068,0.00010845875,0.000035589226,0.00014171343],"category_scores_gemma":[0.00076249894,0.00020807778,0.00043487534,0.0012470798,0.00012340434,0.00009420791,0.000020452699,0.00006069974,0.0000017376973],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0480146,0.0022487785,0.9169344,0.0000900242,0.012983229,0.0000020123837,0.0005783347,0.00040094767,0.0031992863,0.0000046521636,0.0000017111541,0.01554205],"study_design_scores_gemma":[0.2292499,0.009710321,0.73590785,0.00036605785,0.017748043,3.5146638e-8,0.000056909263,0.0052409098,0.0015524735,0.0000140028105,0.000002260603,0.00015125028],"about_ca_topic_score_codex":0.00003957009,"about_ca_topic_score_gemma":0.000027406937,"teacher_disagreement_score":0.1812353,"about_ca_system_score_codex":0.000133855,"about_ca_system_score_gemma":0.00018104675,"threshold_uncertainty_score":0.8485165},"labels":[],"label_agreement":null},{"id":"W3044377510","doi":"10.1007/s13300-020-00884-0","title":"Burden of Diabetes and Prediabetes in Nepal: A Systematic Review and Meta-Analysis","year":2020,"lang":"en","type":"review","venue":"Diabetes Therapy","topic":"Diabetes, Cardiovascular Risks, and Lipoproteins","field":"Medicine","cited_by":90,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Prediabetes; Medicine; Diabetes mellitus; Meta-analysis; Intensive care medicine; Systematic review; MEDLINE; Traditional medicine; Type 2 diabetes; Internal medicine; Endocrinology","score_opus":0.05304638649614409,"score_gpt":0.3116499172448164,"score_spread":0.2586035307486723,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3044377510","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005672956,0.9911522,9.998718e-7,0.00022228676,0.00002918151,0.0076511423,0.00023910143,0.000078183824,0.0000595567],"genre_scores_gemma":[0.00033187307,0.9959413,0.00019100626,0.00062867714,0.000095628595,0.0023677084,0.00020068095,0.00015187482,0.000091254835],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99430203,0.0011453568,0.002122748,0.0011003793,0.0006646388,0.000664871],"domain_scores_gemma":[0.9963011,0.0007520508,0.0010189001,0.0014132608,0.00016078213,0.00035388596],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0018948879,0.001109105,0.026720338,0.00083920895,0.000046161746,0.0000724248,0.0003797233,0.0004296771,0.00012844046],"category_scores_gemma":[0.00052173063,0.00073082733,0.00587165,0.0020091766,0.00025369442,0.0001289246,0.00015298887,0.00057677645,0.0000115239145],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000012528794,0.000048215625,0.000064836175,0.62318546,0.24776582,0.0000053817535,0.00009554813,1.7648146e-7,6.1772624e-7,0.000003835823,0.00002975046,0.12879911],"study_design_scores_gemma":[0.00057897635,0.0002996557,0.00006037548,0.06451569,0.8781288,0.0000021717572,0.000018591429,0.00002410951,0.000011389817,0.000031270803,0.05570464,0.0006243051],"about_ca_topic_score_codex":0.00009666734,"about_ca_topic_score_gemma":0.0000120228715,"teacher_disagreement_score":0.630363,"about_ca_system_score_codex":0.000053592248,"about_ca_system_score_gemma":0.00013086724,"threshold_uncertainty_score":0.9995143},"labels":[],"label_agreement":null},{"id":"W3083494942","doi":"10.1007/s13300-020-00913-y","title":"Insulin Injection Practices in a Population of Canadians with Diabetes: An Observational Study","year":2020,"lang":"en","type":"article","venue":"Diabetes Therapy","topic":"Diabetes Management and Research","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Communications Research Centre Canada; Manitoba Beekeepers' Association; Cégep Saint-Jean-sur-Richelieu","funders":"BD; Dexcom; Novo Nordisk; Sanofi; Janssen Pharmaceuticals; AstraZeneca; Eli Lilly and Company; Amgen","keywords":"Medicine; Insulin; Diabetes mellitus; Insulin pen; Observational study; Population; Injection site; Clinical Practice; Type 2 diabetes; Internal medicine; Surgery; Endocrinology; Physical therapy","score_opus":0.16018355727305933,"score_gpt":0.369118346198004,"score_spread":0.20893478892494466,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3083494942","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966323,0.00016137953,0.0000017147012,0.0017670224,0.000030177256,0.0010884665,0.0000061843893,0.00003829813,0.0002744634],"genre_scores_gemma":[0.9983379,0.000012794799,0.00016647692,0.0010838329,0.00010510475,0.0000804788,0.00013481225,0.000025261055,0.00005331484],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986453,0.0001413159,0.00026539474,0.00027846682,0.00040637676,0.00026313646],"domain_scores_gemma":[0.99925464,0.000085176325,0.00020736932,0.00019357797,0.0001211837,0.00013805146],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004041009,0.0001284836,0.0002837309,0.00021729285,0.000041960207,0.00003069593,0.00011386467,0.000048555114,0.00008583697],"category_scores_gemma":[0.00015578598,0.00010114874,0.000030772662,0.0007963931,0.000036276087,0.0003723524,0.000016503842,0.0001756396,0.0000041993035],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002279378,0.00076731545,0.9781127,0.00007302027,0.00013387333,0.0000036452968,0.0014300385,0.00014963574,0.001534625,0.000029833702,0.00004172104,0.01749564],"study_design_scores_gemma":[0.0026254044,0.0049398537,0.9863879,0.000046332694,0.00002682046,2.9319368e-8,0.00068116246,0.0045668073,0.00027519546,0.000052268806,0.00028656318,0.000111657864],"about_ca_topic_score_codex":0.00083353417,"about_ca_topic_score_gemma":0.0014828157,"teacher_disagreement_score":0.017383981,"about_ca_system_score_codex":0.000050443738,"about_ca_system_score_gemma":0.000087430075,"threshold_uncertainty_score":0.41247258},"labels":[],"label_agreement":null},{"id":"W3083620810","doi":"10.1007/s13300-020-00916-9","title":"A Prospective Longitudinal Study on the Relationship Between Glucose Fluctuation and Cognitive Function in Type 2 Diabetes: PROPOSAL Study Protocol","year":2020,"lang":"en","type":"article","venue":"Diabetes Therapy","topic":"Dementia and Cognitive Impairment Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Japan Society for the Promotion of Science; National Cerebral and Cardiovascular Center; Japan Agency for Medical Research and Development","keywords":"Medicine; Glycated hemoglobin; Type 2 Diabetes Mellitus; Dementia; Internal medicine; Type 2 diabetes; Montreal Cognitive Assessment; Diabetes mellitus; Cognition; Glycemic; Prospective cohort study; Cardiology; Disease; Endocrinology; Insulin; Psychiatry","score_opus":0.08434608687979206,"score_gpt":0.37258313243528035,"score_spread":0.2882370455554883,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3083620810","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.86626786,0.00003689414,0.000009438661,0.0008163026,0.00001737182,0.1326435,0.000003800515,0.000047274225,0.00015755695],"genre_scores_gemma":[0.9341168,0.0000010953103,0.000004636762,0.00032448265,0.00013887767,0.06534694,0.00001793428,0.000026004987,0.000023231032],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99790365,0.00052478403,0.00027384574,0.00046624872,0.00053107593,0.00030038852],"domain_scores_gemma":[0.99870324,0.0007075672,0.000083127416,0.00014456527,0.0002528467,0.000108662774],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00080352474,0.00021058787,0.0002852886,0.00013827246,0.00017817153,0.00007829153,0.000072985866,0.00004993487,0.00009628415],"category_scores_gemma":[0.0006977201,0.00013599894,0.000038770508,0.0007323678,0.00009093788,0.00014817128,0.000045049546,0.00042992132,0.000046966165],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018142867,0.0019683945,0.9830642,0.000030636074,0.00032296006,0.000004680286,0.0034772176,1.1913019e-7,0.00030670696,0.000031968164,0.000016758004,0.008962117],"study_design_scores_gemma":[0.008905648,0.02891917,0.95628977,0.00008131464,0.0001332307,8.307582e-8,0.0036918104,0.000035977788,0.0012943639,0.0005036639,0.000012073542,0.00013287364],"about_ca_topic_score_codex":0.000004648233,"about_ca_topic_score_gemma":0.0000064642777,"teacher_disagreement_score":0.067848936,"about_ca_system_score_codex":0.000046629517,"about_ca_system_score_gemma":0.000098667035,"threshold_uncertainty_score":0.55458754},"labels":[],"label_agreement":null},{"id":"W3087074883","doi":"10.1007/s13300-020-00915-w","title":"Understanding the Clinical Profile of Insulin Degludec, the Latest Basal Insulin Approved for Use in Canada: a Narrative Review","year":2020,"lang":"en","type":"review","venue":"Diabetes Therapy","topic":"Diabetes Management and Research","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Saint John Regional Hospital; University of Manitoba","funders":"Novo Nordisk","keywords":"Insulin degludec; Medicine; Insulin glargine; Insulin; Basal insulin; Pharmacodynamics; Dosing; Hypoglycemia; Basal (medicine); Pharmacology; Intensive care medicine; Pharmacokinetics; Diabetes mellitus; Endocrinology; Type 2 diabetes","score_opus":0.3210177804826985,"score_gpt":0.41142747186803763,"score_spread":0.09040969138533911,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3087074883","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00017072573,0.98485065,0.000018052888,0.0039960006,0.0002246299,0.010355107,0.00013179638,0.000019297397,0.00023375092],"genre_scores_gemma":[0.0002733059,0.9948305,0.00012801643,0.00267739,0.00022857006,0.001291004,0.0002732321,0.00009029177,0.00020768777],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9957784,0.0009880483,0.0014874594,0.0005661209,0.0005783623,0.0006016253],"domain_scores_gemma":[0.99405265,0.004208766,0.0006850184,0.00074636494,0.00016020685,0.00014700029],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025098098,0.0004904583,0.002833346,0.00012199145,0.000125306,0.000049788807,0.0007430532,0.00019487883,0.00007989864],"category_scores_gemma":[0.0012672324,0.00023232076,0.0007204061,0.0010861248,0.00028310178,0.0000759108,0.00016218392,0.001089152,0.0000073034635],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011447885,0.00020774975,0.001113462,0.032199018,0.0013632043,0.000009835755,0.00020892864,6.886987e-7,5.5363887e-7,0.00012635461,0.038984958,0.92567074],"study_design_scores_gemma":[0.0016649223,0.00046538416,0.00028115412,0.029895501,0.0005167158,2.5171303e-7,0.00022750103,0.00033146783,0.0000019131999,0.000108698776,0.9662246,0.00028188736],"about_ca_topic_score_codex":0.0026863175,"about_ca_topic_score_gemma":0.01826754,"teacher_disagreement_score":0.92723966,"about_ca_system_score_codex":0.0005258111,"about_ca_system_score_gemma":0.0030936517,"threshold_uncertainty_score":0.99964654},"labels":[],"label_agreement":null},{"id":"W3088605312","doi":"10.1007/s13300-020-00925-8","title":"The Safety and Efficacy of Second-Generation Basal Insulin Analogues in Adults with Type 2 Diabetes at Risk of Hypoglycemia and Use in Other Special Populations: A Narrative Review","year":2020,"lang":"en","type":"review","venue":"Diabetes Therapy","topic":"Diabetes Management and Research","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Sanofi","keywords":"Medicine; Hypoglycemia; Insulin glargine; Insulin; Diabetes mellitus; Glycated hemoglobin; Type 2 diabetes; Glycemic; Internal medicine; Insulin degludec; Type 2 Diabetes Mellitus; Population; Type 1 diabetes; Endocrinology; Intensive care medicine","score_opus":0.048802162982596015,"score_gpt":0.3233986099411573,"score_spread":0.27459644695856134,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3088605312","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.24079305,0.7569239,9.1116696e-8,0.00007944967,0.000049784314,0.002010815,0.00006747138,0.0000061270916,0.00006931732],"genre_scores_gemma":[0.0022102557,0.99684995,0.00008181981,0.00011423929,0.00019413709,0.00007435864,0.000316712,0.000044405555,0.000114127535],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976071,0.0005891985,0.0008317701,0.00040474196,0.00028757122,0.000279606],"domain_scores_gemma":[0.99826014,0.00072688074,0.0005141399,0.00031643725,0.00010720812,0.00007518849],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00073669537,0.00033409472,0.0016889798,0.00025606417,0.000070617636,0.00002621924,0.00013149601,0.00014528455,0.00007660331],"category_scores_gemma":[0.0004497712,0.00019151025,0.00012495228,0.0008395763,0.00026136375,0.00010652971,0.0000806429,0.00036619083,0.0000022791812],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005560013,0.00013518476,0.07282639,0.0130736325,0.00049987686,0.0000027016667,0.0006493298,0.000001169021,0.000012170281,0.000036959635,0.00047320634,0.9117334],"study_design_scores_gemma":[0.008381833,0.002679591,0.16017301,0.095292196,0.0007579773,4.5060364e-7,0.000100549194,0.0002419702,0.000036697314,0.00007049036,0.73161095,0.00065424433],"about_ca_topic_score_codex":0.000014293747,"about_ca_topic_score_gemma":0.0006431458,"teacher_disagreement_score":0.9110791,"about_ca_system_score_codex":0.000069887894,"about_ca_system_score_gemma":0.000090103604,"threshold_uncertainty_score":0.7809561},"labels":[],"label_agreement":null},{"id":"W3093021192","doi":"10.1007/s13300-020-00939-2","title":"A Coloured Pen Needle Education System Improves Insulin Site Rotation Habits: Results of a Randomized Study","year":2020,"lang":"en","type":"article","venue":"Diabetes Therapy","topic":"Diabetes Management and Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Saint John Regional Hospital; St. Boniface Hospital; Manitoba Hydro; Research Manitoba","funders":"","keywords":"Medicine; Insulin pen; Injection site; Diabetes mellitus; Randomized controlled trial; Insulin; Physical therapy; Surgery; Internal medicine","score_opus":0.01859132040464718,"score_gpt":0.2876809287663831,"score_spread":0.26908960836173595,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3093021192","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9886127,0.001153379,0.0000120920095,0.0024624667,0.00017689612,0.005354684,0.000012109379,0.00010538485,0.0021102983],"genre_scores_gemma":[0.99767464,0.00005666431,0.00020911571,0.00050582015,0.00023842786,0.0004647124,0.00012432343,0.000029750903,0.00069654494],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9980258,0.00037811266,0.0005966523,0.0003075628,0.00044609897,0.00024579006],"domain_scores_gemma":[0.99872106,0.00027180242,0.00027336433,0.00028299086,0.0003147615,0.00013602062],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012187776,0.00016839233,0.00079583406,0.00018925921,0.000055325003,0.000046232795,0.00014853645,0.00006069323,0.000023358094],"category_scores_gemma":[0.0005239788,0.00012389076,0.00017615191,0.00053044927,0.00007590054,0.00011430068,0.000044547844,0.00013735243,0.000040002607],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.28029197,0.008488648,0.10189626,0.0032065709,0.004640267,0.000011310419,0.049810868,0.00005798154,0.23666187,0.00039418496,0.014316677,0.3002234],"study_design_scores_gemma":[0.8198237,0.0098986365,0.098235875,0.0007962287,0.00076021673,2.4197186e-7,0.0152635,0.025955262,0.023672983,0.00011717799,0.0048479033,0.0006283064],"about_ca_topic_score_codex":0.00003453557,"about_ca_topic_score_gemma":0.0000017004207,"teacher_disagreement_score":0.5395317,"about_ca_system_score_codex":0.00004214869,"about_ca_system_score_gemma":0.00013289397,"threshold_uncertainty_score":0.50521183},"labels":[],"label_agreement":null},{"id":"W3114726363","doi":"10.1007/s13300-020-00984-x","title":"Real-World Effectiveness Analysis of Switching From Liraglutide or Dulaglutide to Semaglutide in Patients With Type 2 Diabetes Mellitus: The Retrospective REALISE-DM Study","year":2020,"lang":"en","type":"article","venue":"Diabetes Therapy","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Fraser Health; University of British Columbia","funders":"Novo Nordisk Canada; Novo Nordisk","keywords":"Semaglutide; Dulaglutide; Liraglutide; Medicine; Internal medicine; Tolerability; Type 2 diabetes; Interquartile range; Body mass index; Exenatide; Glycated hemoglobin; Gastroenterology; Type 2 Diabetes Mellitus; Endocrinology; Diabetes mellitus; Adverse effect","score_opus":0.01455503054483066,"score_gpt":0.2668258907390139,"score_spread":0.25227086019418327,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3114726363","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99542564,0.0003062523,0.000010172045,0.00040041542,0.00008654619,0.0033301725,0.000069789996,0.00010765643,0.00026337593],"genre_scores_gemma":[0.99807775,0.000074392585,0.0001946429,0.0010716032,0.000071497554,0.00022000467,0.00016877073,0.00007634191,0.00004498942],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969065,0.0004098385,0.000584651,0.00080929726,0.000694301,0.00059537933],"domain_scores_gemma":[0.9976922,0.00074691256,0.00026247758,0.000822165,0.00024357358,0.000232625],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005607403,0.00047695165,0.0014644577,0.0005793874,0.000102665865,0.000053672033,0.00033288696,0.000060277274,0.00010370904],"category_scores_gemma":[0.00019766057,0.00027918592,0.00022031361,0.004530461,0.00006783408,0.00012324927,0.00012895126,0.00024489322,0.0000141255705],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002373225,0.0013930704,0.97875994,0.0000492561,0.007636328,0.000011407628,0.0028276858,0.00038524522,0.0009102328,0.000029084626,0.00006686936,0.005557674],"study_design_scores_gemma":[0.0056298333,0.0050572236,0.98217046,0.00020070835,0.002283269,4.3233275e-9,0.00038007504,0.00037696047,0.0033927094,0.000059389597,0.00013750745,0.00031186698],"about_ca_topic_score_codex":0.00093185145,"about_ca_topic_score_gemma":0.001142374,"teacher_disagreement_score":0.005353059,"about_ca_system_score_codex":0.0002784155,"about_ca_system_score_gemma":0.000060602822,"threshold_uncertainty_score":0.999966},"labels":[],"label_agreement":null},{"id":"W3125665982","doi":"10.1007/s13300-021-01001-5","title":"Skin Autofluorescence in Young Adult Offspring of Women with Type 1 Diabetes: A Cross-Sectional Case–Control Study","year":2021,"lang":"en","type":"article","venue":"Diabetes Therapy","topic":"Advanced Glycation End Products research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sinai Health System; Lunenfeld-Tanenbaum Research Institute","funders":"Finska Läkaresällskapet; Helsingin ja Uudenmaan Sairaanhoitopiiri","keywords":"Offspring; Medicine; Diabetes mellitus; Type 2 diabetes; Glycated hemoglobin; Cross-sectional study; Population; Type 1 diabetes; Body mass index; Internal medicine; Young adult; Endocrinology; Physiology; Pregnancy; Pathology; Biology","score_opus":0.010792999496902054,"score_gpt":0.2919295167094721,"score_spread":0.28113651721257005,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3125665982","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99871266,0.00077064923,0.000035630663,0.000019561385,0.00006855969,0.0002973178,0.00001991824,0.000009004766,0.000066711946],"genre_scores_gemma":[0.99922127,0.00010748985,0.0002692334,0.00007993597,0.00008270589,0.00010089276,0.000017289174,0.000020315078,0.000100888145],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986263,0.00014609117,0.00022468372,0.0004137115,0.00019942444,0.00038980573],"domain_scores_gemma":[0.99894655,0.00003680134,0.0000722202,0.00039814046,0.00048274896,0.00006354717],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036221658,0.00013073308,0.00018081363,0.00006034522,0.000055021475,0.000028665047,0.00014556485,0.00006355485,0.0000586754],"category_scores_gemma":[0.00020903432,0.000116832656,0.00002704804,0.00033239837,0.00008847899,0.000011305375,0.000034794743,0.00012201042,0.000002140581],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013592566,0.00019744175,0.6761725,0.000013214649,0.000099008255,0.000015842721,0.00023147777,0.0002893917,0.31877968,0.000005164154,0.0000014527965,0.00405888],"study_design_scores_gemma":[0.0015556228,0.00065969065,0.7257676,0.000008325825,0.0000019178135,0.0000067877518,0.0001884827,0.00007571316,0.27153015,0.000020045605,0.00006477498,0.00012085142],"about_ca_topic_score_codex":0.00001469966,"about_ca_topic_score_gemma":0.00008069972,"teacher_disagreement_score":0.049595125,"about_ca_system_score_codex":0.00005267471,"about_ca_system_score_gemma":0.00015040905,"threshold_uncertainty_score":0.47642973},"labels":[],"label_agreement":null},{"id":"W3134228882","doi":"10.1007/s13300-021-01018-w","title":"Efficacy and Safety of Ertugliflozin in Patients With Diabetes Mellitus Inadequately Controlled by Sulfonylurea Monotherapy: a Substudy of VERTIS CV","year":2021,"lang":"en","type":"article","venue":"Diabetes Therapy","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cambridge Cardiac Care Centre","funders":"Merck Sharp and Dohme; Pfizer","keywords":"Medicine; Internal medicine; Cohort; Sulfonylurea; Placebo; Diabetes mellitus; Adverse effect; Gastroenterology; Insulin; Endocrinology","score_opus":0.006761234587167101,"score_gpt":0.2156693836597361,"score_spread":0.208908149072569,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3134228882","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9835022,0.01410344,0.0000038755456,0.00028089355,0.000044578104,0.0017750615,0.000036960737,0.000028253893,0.00022471664],"genre_scores_gemma":[0.9966908,0.0023035936,0.00015565126,0.0003830455,0.000011228761,0.00012055052,0.00017621466,0.00004666773,0.00011222044],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980759,0.00013488707,0.0005956469,0.00039373108,0.0003756035,0.0004242124],"domain_scores_gemma":[0.9987517,0.00030819312,0.00022898258,0.00041438438,0.00018525476,0.000111470814],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024102491,0.0003234166,0.0012428166,0.00017892041,0.00003267694,0.0000169899,0.00010155536,0.000090597765,0.00009193793],"category_scores_gemma":[0.000049428574,0.00023672631,0.000118342556,0.00042353722,0.00013932538,0.00010117433,0.000033696273,0.00010766004,0.0000018197525],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0050495225,0.0033652298,0.9026153,0.00010246954,0.001838584,0.0000037146317,0.0004797452,0.000004670005,0.009485343,0.00005333115,0.000108981396,0.07689309],"study_design_scores_gemma":[0.097460516,0.0031081203,0.8527462,0.00028380178,0.00018902257,3.1181454e-8,0.000058809852,0.000059513386,0.044968333,0.00004332518,0.00085167366,0.000230677],"about_ca_topic_score_codex":0.00001530652,"about_ca_topic_score_gemma":0.00000857018,"teacher_disagreement_score":0.092411,"about_ca_system_score_codex":0.000052408323,"about_ca_system_score_gemma":0.000051535433,"threshold_uncertainty_score":0.96534187},"labels":[],"label_agreement":null},{"id":"W3157765213","doi":"10.1007/s13300-021-01063-5","title":"Evaluating the Effectiveness of Switching to Insulin Degludec from Other Basal Insulins in a Real-World Canadian Population with Type 1 or Type 2 Diabetes: The CAN-TREAT Study","year":2021,"lang":"en","type":"article","venue":"Diabetes Therapy","topic":"Diabetes Management and Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Dalhousie University; Professional Engineers Ontario; CARE Canada; Custom Security Industries (Canada); Western University","funders":"","keywords":"Insulin degludec; Medicine; Type 2 diabetes; Internal medicine; Insulin; Diabetes mellitus; Population; Basal (medicine); Type 1 diabetes; Basal insulin; Endocrinology","score_opus":0.07191577639952101,"score_gpt":0.38472603548779877,"score_spread":0.31281025908827775,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3157765213","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99584967,0.0005071066,0.0000011351597,0.00075426954,0.00014017375,0.0021226797,0.000014410552,0.000024803656,0.0005857347],"genre_scores_gemma":[0.9981557,0.00004222471,0.00012485929,0.000993068,0.00011315794,0.00014513789,0.00006595542,0.000060987255,0.00029892108],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971797,0.0010677129,0.0003118266,0.00040020322,0.00053353293,0.00050704996],"domain_scores_gemma":[0.99757683,0.001245524,0.0000840817,0.0006586323,0.00029305142,0.00014190539],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002012166,0.00023066007,0.00045941168,0.00029424773,0.00016062599,0.000076800214,0.00027201857,0.000057496047,0.00016602961],"category_scores_gemma":[0.00043748325,0.00011633954,0.000052241558,0.0020568746,0.000043226515,0.00006830219,0.00007001246,0.00030086204,0.000011841619],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010292146,0.00030739035,0.9502265,0.000056896457,0.00039709173,0.000013615089,0.0014570917,0.00042186078,0.008338011,0.000020887148,0.000021187872,0.037710268],"study_design_scores_gemma":[0.002618172,0.001995501,0.9896404,0.00045296946,0.000098337594,5.6234132e-8,0.00051182363,0.0011829723,0.0030007018,0.0001785286,0.00015721284,0.00016333043],"about_ca_topic_score_codex":0.08478163,"about_ca_topic_score_gemma":0.38020316,"teacher_disagreement_score":0.29542154,"about_ca_system_score_codex":0.0002166327,"about_ca_system_score_gemma":0.0004894875,"threshold_uncertainty_score":0.92131287},"labels":[],"label_agreement":null},{"id":"W3192341073","doi":"10.1007/s13300-021-01130-x","title":"Efficacy of a New Protocol of Premixed 70/30 Human Insulin in Haitian Youth with Diabetes","year":2021,"lang":"en","type":"article","venue":"Diabetes Therapy","topic":"Diabetes Management and Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Montreal Children's Hospital","funders":"","keywords":"Medicine; Insulin; Diabetes mellitus; Evening; Interquartile range; Morning; Internal medicine; Regular insulin; NPH insulin; Type 2 diabetes; Endocrinology; Hypoglycemia; Insulin glargine","score_opus":0.03840790414353538,"score_gpt":0.32266631259867856,"score_spread":0.28425840845514316,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3192341073","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97077715,0.0002853867,0.00000213552,0.00022296306,0.000020057385,0.025138637,0.000009261979,0.000040753293,0.0035036346],"genre_scores_gemma":[0.9927106,0.000013747594,0.0003346237,0.00017317892,0.00009345827,0.0052052615,0.00006913327,0.000056470926,0.0013435236],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979428,0.00012422913,0.0005027752,0.00037278677,0.0005321716,0.00052525185],"domain_scores_gemma":[0.99877906,0.00010558807,0.00018118553,0.0005778643,0.00019921498,0.0001571085],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038705478,0.00023492517,0.00068672094,0.00030043157,0.000037116923,0.000025044157,0.00022627322,0.00010317494,0.0006281367],"category_scores_gemma":[0.00008718141,0.00017512948,0.00013759956,0.0008031476,0.00018356004,0.000090114576,0.000080651706,0.00024521514,0.000007912058],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005572051,0.0024910409,0.80588263,0.001095557,0.0005633401,0.000016614304,0.0019791108,0.000019973655,0.09225737,0.00016346625,0.00044743743,0.09452624],"study_design_scores_gemma":[0.02513938,0.0029327034,0.5217159,0.0016463334,0.00007177375,7.4927556e-8,0.00035080823,0.00010487668,0.44503823,0.00033009655,0.0023561853,0.0003136964],"about_ca_topic_score_codex":0.000015342008,"about_ca_topic_score_gemma":0.00000990544,"teacher_disagreement_score":0.35278085,"about_ca_system_score_codex":0.00003308317,"about_ca_system_score_gemma":0.00021847639,"threshold_uncertainty_score":0.7141573},"labels":[],"label_agreement":null},{"id":"W4213359410","doi":"10.1007/s13300-015-0124-0","title":"Erratum to: Associations Between Glycemic Control, Depressed Mood, Clinical Depression, and Diabetes Distress Before and After Insulin Initiation: An Exploratory, Post Hoc Analysis","year":2015,"lang":"en","type":"erratum","venue":"Diabetes Therapy","topic":"Diabetes Management and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Eli Lilly (Canada)","funders":"","keywords":"Glycemic; Medicine; Distress; Diabetes mellitus; Depression (economics); Post-hoc analysis; Mood; Insulin; Psychiatry; Internal medicine; Clinical psychology; Endocrinology","score_opus":0.028419742418816205,"score_gpt":0.3313829894486,"score_spread":0.3029632470297838,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4213359410","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98022217,0.011187993,0.0000139882695,0.001528955,0.0015660558,0.0016871792,0.002568442,0.00018438057,0.001040867],"genre_scores_gemma":[0.9751813,0.0015590516,0.00011742043,0.0020130884,0.0028958006,0.00055268896,0.0139324125,0.00018215293,0.0035660935],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99447036,0.00074150483,0.0011793379,0.0013973556,0.0011542657,0.0010571628],"domain_scores_gemma":[0.99557054,0.00050853734,0.00054034975,0.0011552187,0.001017248,0.0012081335],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0016556792,0.00080258236,0.0023487348,0.0010261331,0.00027747874,0.0004725091,0.0004768986,0.0011461484,0.00008751996],"category_scores_gemma":[0.0006008918,0.0006584377,0.00042002002,0.0011455026,0.0003709615,0.0005320116,0.00032480474,0.0014533675,0.00002565617],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005645963,0.00037191724,0.9054641,0.00014764824,0.0049629826,0.000010191805,0.00041734055,0.000002780592,0.000024887513,0.0000019582346,0.05783518,0.030196408],"study_design_scores_gemma":[0.0067634117,0.0030364867,0.96850556,0.00032281002,0.0030245911,7.5210345e-8,0.00009981029,0.00060813536,0.000020819474,0.00027648557,0.016615752,0.000726058],"about_ca_topic_score_codex":0.000008917231,"about_ca_topic_score_gemma":0.00019646276,"teacher_disagreement_score":0.063041456,"about_ca_system_score_codex":0.00011946936,"about_ca_system_score_gemma":0.00025361418,"threshold_uncertainty_score":0.9995867},"labels":[],"label_agreement":null},{"id":"W4214539958","doi":"10.1007/s13300-022-01216-0","title":"Defining Minimum Necessary Communication During Care Transitions for Patients on Antihyperglycemic Medication: Consensus of the Care Transitions Task Force of the IPRO Hypoglycemia Coalition","year":2022,"lang":"en","type":"article","venue":"Diabetes Therapy","topic":"Hyperglycemia and glycemic control in critically ill and hospitalized patients","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of British Columbia","funders":"National Institute on Aging; National Institute of Diabetes and Digestive and Kidney Diseases; Abbott Diabetes Care; Centers for Medicare and Medicaid Services; U.S. Department of Veterans Affairs; Syracuse University; Centers for Disease Control and Prevention","keywords":"Task (project management); Hypoglycemia; Medicine; Task force; Diabetes mellitus; Patient care; Intensive care medicine; Nursing; Public administration; Political science; Management; Endocrinology","score_opus":0.00876583446230965,"score_gpt":0.24807951298817388,"score_spread":0.23931367852586422,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4214539958","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99090475,0.0021460606,0.000013398924,0.0026836868,0.00031687148,0.0015937506,0.0016981742,0.00003059241,0.0006127227],"genre_scores_gemma":[0.9974378,0.00010349587,0.000101155725,0.00082991604,0.00003284814,0.0005113792,0.000920977,0.0000348744,0.000027586239],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981264,0.00023316583,0.00056947634,0.00026971407,0.0005221076,0.00027912098],"domain_scores_gemma":[0.9982061,0.00031474224,0.00019914884,0.0007448915,0.00046718938,0.00006794337],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011354232,0.00020295748,0.0003892494,0.00008802417,0.00087465777,0.000008274259,0.000358391,0.00010688518,0.000050053924],"category_scores_gemma":[0.00008043251,0.00014582038,0.0003987901,0.00031190258,0.000315873,0.00004289083,0.00004975228,0.00032489872,5.857168e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020669846,0.005979435,0.48834878,0.0043472378,0.001896126,0.000003853607,0.13225599,0.0018143385,0.30251965,0.013523665,0.0021014092,0.026539655],"study_design_scores_gemma":[0.15013753,0.02003096,0.46152514,0.005777755,0.0037450434,0.000039016468,0.1129558,0.002572837,0.22305655,0.004430154,0.013199705,0.0025294903],"about_ca_topic_score_codex":0.000016653734,"about_ca_topic_score_gemma":0.0000075265184,"teacher_disagreement_score":0.1294677,"about_ca_system_score_codex":0.00012761608,"about_ca_system_score_gemma":0.00016755976,"threshold_uncertainty_score":0.67272484},"labels":[],"label_agreement":null},{"id":"W4220773185","doi":"10.1007/s13300-022-01247-7","title":"Clinical Use of Insulin Glargine 300 U/mL in Adults with Type 2 Diabetes: Hypothetical Case Studies","year":2022,"lang":"en","type":"review","venue":"Diabetes Therapy","topic":"Diabetes Management and Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Sanofi","keywords":"Medicine; Insulin glargine; Basal insulin; Insulin; Context (archaeology); Hypoglycemia; Diabetes mellitus; Basal (medicine); Type 2 diabetes; Internal medicine; Endocrinology; Intensive care medicine","score_opus":0.2005561795537173,"score_gpt":0.42984573758603817,"score_spread":0.22928955803232087,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220773185","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.1380953,0.85891217,1.5639696e-7,0.00006489278,0.00030332565,0.0023470796,0.000057888992,0.00006103049,0.00015816245],"genre_scores_gemma":[0.000934128,0.9967421,0.00031353565,0.00027608292,0.00023602326,0.00041249453,0.00026860225,0.0001778713,0.0006391393],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99506396,0.00089812535,0.0014913082,0.0008867181,0.00076851324,0.000891379],"domain_scores_gemma":[0.99536157,0.0026692543,0.00045538743,0.0010502603,0.0002267013,0.00023681924],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0017292252,0.00068749394,0.004093877,0.0007837997,0.00008176526,0.000038321767,0.00038486705,0.00033535965,0.00063578447],"category_scores_gemma":[0.0008157314,0.00044238116,0.00064352754,0.0016672562,0.0006201181,0.00012041904,0.00032827447,0.0013760485,0.000041304396],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028263396,0.0013044417,0.010991645,0.016133467,0.0024459604,0.0010104076,0.00011931653,0.0000011225966,3.3185097e-7,0.0000247471,0.0007789953,0.9669069],"study_design_scores_gemma":[0.0038843218,0.004360684,0.00035049077,0.014051528,0.0007272673,0.000011899875,0.00008892715,0.00005684031,0.0000024637754,0.000023572555,0.975924,0.00051800284],"about_ca_topic_score_codex":0.000005133398,"about_ca_topic_score_gemma":0.000007896343,"teacher_disagreement_score":0.975145,"about_ca_system_score_codex":0.00014342235,"about_ca_system_score_gemma":0.0003002434,"threshold_uncertainty_score":0.99980277},"labels":[],"label_agreement":null},{"id":"W4220787584","doi":"10.1007/s13300-022-01213-3","title":"Effective Overall Glycaemic Control with Fast-Acting Insulin Aspart Across Patients with Different Baseline Characteristics: A Post Hoc Analysis of the Onset 9 Trial","year":2022,"lang":"en","type":"article","venue":"Diabetes Therapy","topic":"Diabetes Management and Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Swedish Orphan Biovitrum; Dexcom; Novo Nordisk; Sanofi; Servier; Amgen; Pfizer; AstraZeneca; Daiichi Sankyo Europe; Eli Lilly and Company; GlaxoSmithKline","keywords":"Insulin aspart; Medicine; Postprandial; Post-hoc analysis; Internal medicine; Type 2 diabetes; Insulin; Diabetes mellitus; Endocrinology","score_opus":0.007433118407592998,"score_gpt":0.253035676854968,"score_spread":0.24560255844737497,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220787584","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958471,0.00010875897,0.000022125783,0.00030649014,0.00013684553,0.002807447,0.0006995512,0.000033167835,0.00003852351],"genre_scores_gemma":[0.9977291,0.000015183207,0.000010246109,0.0008854221,0.0000839425,0.0004862259,0.0005680312,0.000041832853,0.00017999332],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99737465,0.0004919099,0.00034847128,0.0003760532,0.00089814176,0.0005107474],"domain_scores_gemma":[0.99823433,0.00052047154,0.00035249034,0.0005198958,0.0002816256,0.00009119746],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006598898,0.00027110218,0.0008240585,0.00022415622,0.00028188972,0.000050939547,0.00027154738,0.00004169203,0.00025921108],"category_scores_gemma":[0.00010948619,0.00014375705,0.00026161727,0.00082086725,0.00015302146,0.00006917791,0.0001318311,0.00040338738,0.0000016645964],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.086111166,0.0016840919,0.8509013,0.000050905877,0.005764054,0.0000038032724,0.0006748963,0.000094826886,0.0009511348,0.0000029948064,0.000042308988,0.053718477],"study_design_scores_gemma":[0.076660894,0.010495335,0.9081968,0.00006464771,0.00085277355,7.047598e-8,0.00014096401,0.0023986266,0.00044002003,0.0000027650829,0.000547867,0.00019925069],"about_ca_topic_score_codex":0.00001470406,"about_ca_topic_score_gemma":0.000011524814,"teacher_disagreement_score":0.05729545,"about_ca_system_score_codex":0.000121505065,"about_ca_system_score_gemma":0.000051262316,"threshold_uncertainty_score":0.58622426},"labels":[],"label_agreement":null},{"id":"W4220897970","doi":"10.1007/s13300-022-01231-1","title":"Exploring a Suitable Marker of Glycemic Response to Dulaglutide in Patients with Type 2 Diabetes: A Retrospective Study","year":2022,"lang":"en","type":"article","venue":"Diabetes Therapy","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Japan Society for the Promotion of Science","keywords":"Dulaglutide; Glycemic; Medicine; Internal medicine; Postprandial; Diabetes mellitus; Type 2 diabetes; Confounding; Endocrinology; Insulin; Liraglutide","score_opus":0.025611590432546776,"score_gpt":0.24125545096083223,"score_spread":0.21564386052828546,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220897970","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99683356,0.00019541822,2.5572757e-7,0.00010455818,0.00014287303,0.002420356,0.00001824666,0.00005503762,0.00022966461],"genre_scores_gemma":[0.99810255,0.000014343769,0.00009285028,0.0003476602,0.000015391564,0.0010046196,0.00003109447,0.000055645323,0.00033584342],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99802256,0.00021648311,0.0002917073,0.00041817556,0.00055399607,0.0004970986],"domain_scores_gemma":[0.99908465,0.0000940308,0.000096723394,0.00050751626,0.00011623937,0.00010085688],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000623896,0.00023238751,0.0005217834,0.00047313317,0.00008390595,0.0000144662035,0.00015922295,0.000019434825,0.00023359028],"category_scores_gemma":[0.0000708228,0.00019450785,0.000062187006,0.0011678109,0.000028087463,0.00014709293,0.00015049159,0.00017203351,0.000010882171],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016998496,0.0030196102,0.9722612,0.00001776425,0.0004906946,0.0000096162585,0.0020759297,0.00004683129,0.0012382938,0.000005554056,0.000091551075,0.0037444711],"study_design_scores_gemma":[0.01090986,0.02680614,0.9592585,0.00006513546,0.00006606262,2.684733e-8,0.0009163893,0.000013208717,0.0007170995,0.000015309079,0.0010400601,0.00019223931],"about_ca_topic_score_codex":0.000019459032,"about_ca_topic_score_gemma":0.000006815131,"teacher_disagreement_score":0.02378653,"about_ca_system_score_codex":0.00040348034,"about_ca_system_score_gemma":0.00004942231,"threshold_uncertainty_score":0.79318},"labels":[],"label_agreement":null},{"id":"W4310350904","doi":"10.1007/s13300-022-01346-5","title":"Sustained Improvement in Glycemic Control in Emerging Adults with Type 1 Diabetes 2 Years After the Start of the COVID-19 Pandemic","year":2022,"lang":"en","type":"article","venue":"Diabetes Therapy","topic":"Diabetes Management and Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. Michael's Hospital","funders":"University of Toronto","keywords":"Medicine; Glycemic; Pandemic; Diabetes mellitus; Type 2 diabetes; Coronavirus disease 2019 (COVID-19); Type 1 diabetes; Diabetes management; Young adult; Public health; Referral; Internal medicine; Pediatrics; Emergency medicine; Disease; Endocrinology; Family medicine; Infectious disease (medical specialty)","score_opus":0.012556922968457175,"score_gpt":0.26641797842853226,"score_spread":0.2538610554600751,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310350904","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934089,0.0017940212,0.0000010531719,0.002764445,0.00009445733,0.0017929057,0.000015315572,0.00002449577,0.00010437796],"genre_scores_gemma":[0.99311376,0.00011987824,0.000006224303,0.005788127,0.000034402277,0.0005677527,0.000015717149,0.000032057902,0.00032208223],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99806154,0.00023184765,0.00030450366,0.00027762275,0.0005602837,0.00056422665],"domain_scores_gemma":[0.99906224,0.00022531844,0.000108256616,0.0004752237,0.000055321514,0.00007364775],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009829345,0.00016612913,0.00031863007,0.00023622738,0.000086100394,0.00001735797,0.0003581701,0.00003666263,0.00041735708],"category_scores_gemma":[0.000076412194,0.00009343527,0.00008396871,0.000914396,0.00016606215,0.000051445695,0.00020368796,0.0004279887,0.000002268043],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037859385,0.00023560836,0.97391504,0.00011779562,0.00014681714,0.000010471476,0.0016192201,0.00043531897,0.004414354,0.000013782055,0.00030478655,0.015000839],"study_design_scores_gemma":[0.05379904,0.007285563,0.8889141,0.0003112277,0.00011679629,8.094467e-7,0.007586011,0.007093728,0.00091603753,0.0008440444,0.032483324,0.0006493078],"about_ca_topic_score_codex":0.000056852274,"about_ca_topic_score_gemma":0.00008775567,"teacher_disagreement_score":0.08500096,"about_ca_system_score_codex":0.00025363284,"about_ca_system_score_gemma":0.00018623086,"threshold_uncertainty_score":0.45697674},"labels":[],"label_agreement":null},{"id":"W4312211549","doi":"10.1007/s13300-022-01353-6","title":"Ease of Use of the iGlarLixi SoloStar Pen from the LixiLan ONE CAN Pen Sub-Study: Questionnaire Findings from People Living with Type 2 Diabetes and Their HealthCare Providers","year":2022,"lang":"en","type":"article","venue":"Diabetes Therapy","topic":"Diabetes Management and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital; Western University; McMaster University; Sanofi (Canada); McGill University Health Centre","funders":"Sanofi","keywords":"Medicine; Health care; Nursing; Gerontology; Family medicine; Internet privacy; Computer science","score_opus":0.026664615773109097,"score_gpt":0.2471243322216852,"score_spread":0.2204597164485761,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312211549","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98799646,0.003113826,4.8564823e-7,0.0066746334,0.00010250254,0.0019012342,0.000165931,0.000033999415,0.000010934372],"genre_scores_gemma":[0.9981629,0.00016869491,0.000027053093,0.0011811208,0.00006653713,0.0001510633,0.00008969316,0.000050665185,0.00010226487],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99773383,0.000566391,0.00030301372,0.00038994197,0.00059084775,0.00041594933],"domain_scores_gemma":[0.99801874,0.0007728074,0.00020127199,0.000727123,0.00017224452,0.000107804015],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00059778057,0.00024045353,0.000508534,0.00009816529,0.00039910665,0.000072625524,0.00042674714,0.000048674632,0.00018648361],"category_scores_gemma":[0.00021394956,0.00013122041,0.000098503435,0.0005139918,0.00024092966,0.00013007598,0.00039307278,0.00041077984,0.0000013385568],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017244164,0.0004779863,0.9715122,0.00008509362,0.0006209091,9.632253e-7,0.013991024,0.000010102489,0.006876777,0.000010842729,0.00039848196,0.005843153],"study_design_scores_gemma":[0.0013729632,0.0018112801,0.98550326,0.00039825914,0.00010727054,6.137834e-8,0.006292646,0.00024162402,0.0037114546,0.0001607165,0.00023708587,0.00016337293],"about_ca_topic_score_codex":0.0026929097,"about_ca_topic_score_gemma":0.0013470249,"teacher_disagreement_score":0.013991041,"about_ca_system_score_codex":0.00006253071,"about_ca_system_score_gemma":0.00017611503,"threshold_uncertainty_score":0.5351013},"labels":[],"label_agreement":null},{"id":"W4323920834","doi":"10.1007/s13300-023-01389-2","title":"Correlation Between Time in Range and HbA1c in People with Type 2 Diabetes on Basal Insulin: Post Hoc Analysis of the SWITCH PRO Study","year":2023,"lang":"en","type":"article","venue":"Diabetes Therapy","topic":"Diabetes Management and Research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"LMC Diabetes & Endocrinology (Canada)","funders":"Novo Nordisk","keywords":"Medicine; Basal (medicine); Post-hoc analysis; Type 2 diabetes; Diabetes mellitus; Basal insulin; Insulin; Post hoc; Internal medicine; Endocrinology","score_opus":0.018606087282138563,"score_gpt":0.2811965862677894,"score_spread":0.2625904989856508,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4323920834","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973331,0.00025915276,1.636803e-7,0.00071649475,0.000033185515,0.0013904587,0.000010716507,0.000032088366,0.0002246037],"genre_scores_gemma":[0.999107,0.00007854168,0.00000517436,0.00015135255,0.000030322562,0.00006293704,0.00009433958,0.000025536596,0.000444783],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984862,0.0001756093,0.00026426176,0.00028831474,0.00044725352,0.0003383467],"domain_scores_gemma":[0.99908954,0.00034862687,0.00008260752,0.00033818345,0.00009120591,0.000049861894],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00085044774,0.00015756897,0.000525814,0.00095199957,0.00004440074,0.000024227258,0.00012897042,0.00006540708,0.00006153889],"category_scores_gemma":[0.00007609336,0.00009531538,0.000062976185,0.0045501688,0.0000669235,0.000073731164,0.000067986366,0.00021982809,0.00002147239],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024911726,0.00037265147,0.9824265,0.00003886742,0.0007684821,0.0000023971916,0.0012478329,0.00016320401,0.00056019,0.0000028596933,0.000055381315,0.014112477],"study_design_scores_gemma":[0.002992665,0.002297208,0.98658264,0.000091451926,0.00021100596,4.5170343e-9,0.00022187256,0.007238223,0.00019476759,0.000024925192,0.000037930495,0.00010733056],"about_ca_topic_score_codex":0.00002554055,"about_ca_topic_score_gemma":0.00014505255,"teacher_disagreement_score":0.014005147,"about_ca_system_score_codex":0.000037110927,"about_ca_system_score_gemma":0.000035111716,"threshold_uncertainty_score":0.38868484},"labels":[],"label_agreement":null},{"id":"W4377011531","doi":"10.1007/s13300-023-01418-0","title":"Guardians For Health: A Practical Approach to Improving Quality of Life and Longevity in People with Type 2 Diabetes","year":2023,"lang":"en","type":"review","venue":"Diabetes Therapy","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University of Manitoba; Dalhousie University","funders":"Boehringer Ingelheim; Yale University","keywords":"Medicine; Guideline; Type 2 diabetes; Diabetes mellitus; Disease; Intensive care medicine; Quality of life (healthcare); Health care; MEDLINE; Gerontology; Family medicine; Nursing; Internal medicine; Pathology","score_opus":0.5492886206901549,"score_gpt":0.5077282750631176,"score_spread":0.041560345627037365,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4377011531","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.020957135,0.9685515,0.00038755452,0.003549719,0.00025242296,0.005141429,0.0010230955,0.000058464404,0.000078644334],"genre_scores_gemma":[0.0007978245,0.98531646,0.0062325085,0.0047604083,0.00030377964,0.0020779464,0.0002614824,0.00018289372,0.000066714885],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.99224544,0.0009026243,0.004990314,0.0009877261,0.00011967589,0.00075420015],"domain_scores_gemma":[0.9904645,0.004698448,0.0037109677,0.00070097425,0.00008851419,0.00033657675],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.023321316,0.00044021185,0.0055907564,0.0006133084,0.000109662535,0.00008395238,0.00028708228,0.00032067066,0.000013122903],"category_scores_gemma":[0.005787733,0.0004459527,0.00027032656,0.0007437337,0.00007421111,0.00023026833,0.000069684334,0.00032329644,0.00007838704],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017871421,0.0016043204,0.16675425,0.39837885,0.0025808534,3.5999753e-7,0.007663486,0.00006557113,8.0845024e-7,0.023015404,0.013195396,0.386562],"study_design_scores_gemma":[0.003071603,0.0017954886,0.032867018,0.0070476453,0.00007280373,8.8493624e-7,0.00072750414,0.0013636434,5.6527693e-7,0.0018615931,0.94894373,0.0022475289],"about_ca_topic_score_codex":0.0006036199,"about_ca_topic_score_gemma":0.00036853447,"teacher_disagreement_score":0.93574834,"about_ca_system_score_codex":0.00042591043,"about_ca_system_score_gemma":0.00096239353,"threshold_uncertainty_score":0.99979925},"labels":[],"label_agreement":null},{"id":"W4378783299","doi":"10.1007/s13300-023-01413-5","title":"Greater Combined Reductions of HbA1c ≥ 1.0% and Body Weight Loss ≥ 5.0% or ≥ 10.0% with Orally Administered Semaglutide Versus Comparators","year":2023,"lang":"en","type":"article","venue":"Diabetes Therapy","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"Novo Nordisk; Steno Diabetes Center Copenhagen","keywords":"Semaglutide; Liraglutide; Medicine; Empagliflozin; Sitagliptin; Weight loss; Placebo; Type 2 diabetes; Internal medicine; Diabetes mellitus; Endocrinology; Obesity","score_opus":0.03918269970728713,"score_gpt":0.28839835964490207,"score_spread":0.24921565993761494,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4378783299","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99565965,0.00017568926,0.0000014939553,0.0014495051,0.00020536671,0.0006899966,0.000025007419,0.00020352857,0.0015897837],"genre_scores_gemma":[0.98888993,0.000239024,0.00033064507,0.00016480312,0.00006524525,0.0001269629,0.00016024275,0.000049275062,0.009973844],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987123,0.00004242891,0.00026606605,0.0003358976,0.00024855867,0.00039474893],"domain_scores_gemma":[0.9991319,0.000096482545,0.00010696649,0.0004121803,0.000094650066,0.00015780622],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000118458935,0.0002653718,0.0005145235,0.00023836843,0.000093770905,0.000028530487,0.00009657995,0.000059287355,0.0005538246],"category_scores_gemma":[0.000012266771,0.00017127629,0.00007919719,0.00057570357,0.00022215047,0.00008006077,0.000044660468,0.00007322615,0.00009581841],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02166258,0.0021866534,0.8716161,0.0006680378,0.009775419,0.00027116254,0.0016254869,0.000012335319,0.01395088,0.0014809774,0.05745846,0.019291863],"study_design_scores_gemma":[0.066683345,0.02950344,0.7046645,0.0005741174,0.0015502981,0.0000070487795,0.00072642486,0.0006216846,0.062620975,0.0002534342,0.13169141,0.00110329],"about_ca_topic_score_codex":0.000004161016,"about_ca_topic_score_gemma":0.0000047889507,"teacher_disagreement_score":0.16695163,"about_ca_system_score_codex":0.000034317716,"about_ca_system_score_gemma":0.00005403663,"threshold_uncertainty_score":0.6984445},"labels":[],"label_agreement":null},{"id":"W4379260635","doi":"10.1007/s13300-023-01423-3","title":"Real-World Effects of Second-Generation Versus Earlier Intermediate/Basal Insulin Analogues on Rates of Hypoglycemia in Adults with Type 1 and 2 Diabetes (iNPHORM, US)","year":2023,"lang":"en","type":"article","venue":"Diabetes Therapy","topic":"Diabetes Management and Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Robarts Clinical Trials; Western University","funders":"Sanofi Pasteur","keywords":"Medicine; Hypoglycemia; Basal (medicine); Diabetes mellitus; Basal insulin; Internal medicine; Insulin; Type 1 diabetes; Endocrinology; Type 2 diabetes","score_opus":0.023049317534895943,"score_gpt":0.2940169029136934,"score_spread":0.2709675853787975,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379260635","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976023,0.0005948874,6.165329e-8,0.000086064785,0.0002304616,0.0006904871,0.00001118245,0.000043580763,0.0007409943],"genre_scores_gemma":[0.997394,0.0015710455,0.00003935374,0.000109294146,0.00011673541,0.00006115453,0.00024027897,0.000040322524,0.00042779857],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985385,0.00010426795,0.00030895247,0.00031495196,0.00033426948,0.0003990779],"domain_scores_gemma":[0.99886477,0.00050193456,0.00012142773,0.00027718616,0.00014405833,0.000090616064],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035091257,0.00021095668,0.00049418176,0.000742647,0.000030448266,0.000019318511,0.000117558666,0.00008642398,0.000063756226],"category_scores_gemma":[0.00011404915,0.00015435652,0.000049681792,0.0011614701,0.0002018469,0.00010767459,0.000052857704,0.00019423521,0.000018724868],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028918355,0.00030276974,0.8612044,0.0010376098,0.00038759937,0.00001247242,0.0005277947,0.000024849081,0.10112925,0.00005079719,0.0011759205,0.031254735],"study_design_scores_gemma":[0.0072484175,0.004781768,0.8012455,0.00062667596,0.000025902029,1.02907824e-8,0.000046785124,0.0011698358,0.1845198,0.00004317264,0.00014633441,0.00014578033],"about_ca_topic_score_codex":0.00002319252,"about_ca_topic_score_gemma":0.00019493856,"teacher_disagreement_score":0.08339055,"about_ca_system_score_codex":0.000034710276,"about_ca_system_score_gemma":0.000049460163,"threshold_uncertainty_score":0.6294476},"labels":[],"label_agreement":null},{"id":"W4381105997","doi":"10.1007/s13300-023-01429-x","title":"Healthcare Professionals’ Knowledge of and Attitudes Towards the Use of Time in Range in Diabetes Management: Online Survey Across Seven Countries","year":2023,"lang":"en","type":"article","venue":"Diabetes Therapy","topic":"Hyperglycemia and glycemic control in critically ill and hospitalized patients","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Trillium Health Centre","funders":"Novo Nordisk","keywords":"Medicine; Diabetes mellitus; Health professionals; Diabetes management; Family medicine; Regimen; Health care; Nursing; Type 2 diabetes; Internal medicine","score_opus":0.07840912946528061,"score_gpt":0.3713349090589144,"score_spread":0.2929257795936338,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4381105997","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99368024,0.0036487496,1.6122087e-7,0.0015084429,0.00007709063,0.0006400902,0.0004037509,0.000020516329,0.000020979985],"genre_scores_gemma":[0.9961136,0.0026739344,0.000027188833,0.0005597503,0.00002258108,0.00006514292,0.00019413796,0.00001874853,0.0003248955],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985697,0.00021420787,0.00044111806,0.00021068209,0.00019526051,0.00036903255],"domain_scores_gemma":[0.9987974,0.00067942403,0.000072614734,0.00023083191,0.0001624098,0.000057275767],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007037982,0.00015201954,0.00053145946,0.00013581332,0.000044690085,0.000011045319,0.00011695642,0.000101496764,0.00002448927],"category_scores_gemma":[0.0001253412,0.00010002179,0.000059672027,0.00048036536,0.00021171792,0.000076544726,0.00008446284,0.00015397239,0.000004986859],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033814122,0.0005229352,0.9730645,0.0005794009,0.0001023804,0.000003345351,0.004081906,0.0000030505905,0.00023533103,0.000040622897,0.00016044242,0.020867981],"study_design_scores_gemma":[0.0036744871,0.00031671874,0.9926214,0.00078696554,0.00001213419,1.14131105e-7,0.00031211894,0.000584802,0.0002042581,0.00008556728,0.0012989726,0.000102448656],"about_ca_topic_score_codex":0.00017227921,"about_ca_topic_score_gemma":0.0003468361,"teacher_disagreement_score":0.020765532,"about_ca_system_score_codex":0.000023312248,"about_ca_system_score_gemma":0.000047211655,"threshold_uncertainty_score":0.407877},"labels":[],"label_agreement":null},{"id":"W4382182323","doi":"10.1007/s13300-023-01436-y","title":"The Hidden Burden—Exploring Depression Risk in Patients with Diabetic Nephropathy: A Systematic Review and Meta-Analysis","year":2023,"lang":"en","type":"review","venue":"Diabetes Therapy","topic":"Diabetes Management and Education","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Diabetic nephropathy; Diabetes mellitus; Observational study; Nephropathy; Meta-analysis; Internal medicine; Odds ratio; Depression (economics); Randomized controlled trial; Type 2 diabetes; Confidence interval; Endocrinology","score_opus":0.085483647586891,"score_gpt":0.31659712898750236,"score_spread":0.23111348140061136,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4382182323","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0027850058,0.99036306,6.3777765e-7,0.00010087781,0.00006657932,0.0065556443,0.000023566801,0.000077404926,0.000027208216],"genre_scores_gemma":[0.00019273096,0.9930406,0.000024849072,0.00018372553,0.00004954211,0.0056318073,0.00026077125,0.00011293605,0.00050302997],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.996553,0.0007234943,0.001077014,0.00061255303,0.0005330183,0.00050089374],"domain_scores_gemma":[0.99685436,0.0007968399,0.00094145344,0.0011676364,0.00011753556,0.00012215508],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0016039851,0.0006010022,0.0060693673,0.00055823405,0.00016379243,0.00014169367,0.0003239281,0.000110681154,0.000042726977],"category_scores_gemma":[0.0002649507,0.0002802141,0.0011115524,0.002040727,0.00006513546,0.00014860208,0.000090165806,0.00037369842,0.000061252635],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000067648443,0.00010903533,0.008169104,0.69115025,0.17110962,0.0000017236906,0.00013603627,5.79352e-7,9.402257e-9,0.0000047498997,0.000116208874,0.12919594],"study_design_scores_gemma":[0.00044870315,0.00014682653,0.0028667618,0.06918059,0.91427904,7.835435e-8,0.00003015093,0.000008361698,1.3935379e-7,0.000021310156,0.012620718,0.000397334],"about_ca_topic_score_codex":0.00001531598,"about_ca_topic_score_gemma":0.000006626668,"teacher_disagreement_score":0.7431694,"about_ca_system_score_codex":0.00009110237,"about_ca_system_score_gemma":0.000050832205,"threshold_uncertainty_score":0.999965},"labels":[],"label_agreement":null},{"id":"W4386945140","doi":"10.1007/s13300-023-01468-4","title":"Insulin Therapy for the Management of Diabetes Mellitus: A Narrative Review of Innovative Treatment Strategies","year":2023,"lang":"en","type":"review","venue":"Diabetes Therapy","topic":"Diabetes Management and Research","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Insulin; Diabetes mellitus; Intensive care medicine; Type 2 diabetes; Type 2 Diabetes Mellitus; Dosing; Internal medicine; Endocrinology","score_opus":0.11174396295785947,"score_gpt":0.41557464660919746,"score_spread":0.303830683651338,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386945140","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00039937664,0.9841482,0.0000066188686,0.0003534296,0.00020195088,0.01374383,0.00020833657,0.00007537559,0.00086285186],"genre_scores_gemma":[0.00003675791,0.9913365,0.00021519705,0.00022915626,0.0001541433,0.005814574,0.0006242269,0.00015362239,0.001435769],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99615145,0.0003078599,0.0014838636,0.00063916703,0.00070115743,0.0007164948],"domain_scores_gemma":[0.99578816,0.0012930011,0.0010575211,0.0011131123,0.00066682865,0.00008139773],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0015089919,0.00081021135,0.003751825,0.00047663107,0.00012468862,0.000046454257,0.0006862232,0.00021089912,0.00014357631],"category_scores_gemma":[0.000043190405,0.00041213844,0.0012591467,0.0025010288,0.00043018057,0.0001042413,0.000117450305,0.00028144656,0.000020729882],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000042285694,0.00047742552,0.000018664803,0.18203454,0.013828275,0.0000016645179,0.00034339796,4.2686136e-7,0.000005040752,0.0007681606,0.00097791,0.8015022],"study_design_scores_gemma":[0.00226267,0.002786661,0.0000841067,0.14716361,0.00117481,5.3423264e-8,0.0006451995,0.000010313711,0.00015782457,0.00037704743,0.8449801,0.00035755872],"about_ca_topic_score_codex":0.000003022917,"about_ca_topic_score_gemma":5.808183e-7,"teacher_disagreement_score":0.84400225,"about_ca_system_score_codex":0.00013547808,"about_ca_system_score_gemma":0.00038071116,"threshold_uncertainty_score":0.99983305},"labels":[],"label_agreement":null},{"id":"W4387033802","doi":"10.1007/s13300-023-01464-8","title":"Humanistic and Economic Burden of Patients with Cardiorenal Metabolic Conditions: A Systematic Review","year":2023,"lang":"en","type":"review","venue":"Diabetes Therapy","topic":"Chronic Kidney Disease and Diabetes","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Eli Lilly and Company; Boehringer Ingelheim","keywords":"Medicine; Population; MEDLINE; Health care; Ethnic group; Disease burden; Intensive care medicine; Gerontology; Environmental health","score_opus":0.024788245640435684,"score_gpt":0.3097358291103745,"score_spread":0.2849475834699388,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387033802","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0014269054,0.99286145,1.0826509e-7,0.000012367738,0.00006293878,0.0044795005,0.0010355248,0.00006250406,0.000058720114],"genre_scores_gemma":[0.00018307022,0.99653554,0.0000066536413,0.00015994188,0.00012154831,0.0010854263,0.0017228822,0.00010608101,0.00007886605],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9979668,0.0001762338,0.00091489556,0.00039510592,0.00024666268,0.00030027557],"domain_scores_gemma":[0.9980963,0.00034580685,0.00060873723,0.0006464331,0.00009526311,0.00020748132],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002589644,0.00046418552,0.0050341096,0.00021864445,0.00005000843,0.00002312978,0.00015343135,0.000119437085,0.00013656882],"category_scores_gemma":[0.000120862256,0.00029227807,0.00057483336,0.00020047848,0.00014053371,0.000051522868,0.000036507514,0.00015577428,0.00010929192],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000041709,0.000052151983,0.00022254777,0.9871169,0.0035561197,0.0000027228164,0.000016916114,7.934048e-8,9.682822e-8,0.000080427686,0.0004995978,0.008448294],"study_design_scores_gemma":[0.0014328182,0.00028294598,0.00030297067,0.9097669,0.020918785,0.0000018527552,0.0000061657215,0.000002848815,0.0000010435618,0.000040246836,0.066847555,0.00039588555],"about_ca_topic_score_codex":0.000006762033,"about_ca_topic_score_gemma":4.7662354e-7,"teacher_disagreement_score":0.07734999,"about_ca_system_score_codex":0.000081410064,"about_ca_system_score_gemma":0.00048265493,"threshold_uncertainty_score":0.9999529},"labels":[],"label_agreement":null},{"id":"W4387219824","doi":"10.1007/s13300-023-01479-1","title":"Addressing Insulin Injection Technique: A Follow-up Study of Canadian Patients with Diabetes","year":2023,"lang":"en","type":"article","venue":"Diabetes Therapy","topic":"Intramuscular injections and effects","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Communications Research Centre Canada; Cégep Saint-Jean-sur-Richelieu","funders":"","keywords":"Medicine; Diabetes mellitus; Insulin; Insulin pen; Diabetes management; Intensive care medicine; Type 2 diabetes; Internal medicine; Endocrinology","score_opus":0.027037812368847558,"score_gpt":0.2688425599392266,"score_spread":0.24180474757037906,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387219824","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99757046,0.00007616105,0.000003927198,0.0000473702,0.00022316881,0.0016341059,0.0000127038165,0.00014749529,0.00028464213],"genre_scores_gemma":[0.99920857,0.000015176245,0.00006659464,0.00013987572,0.00006194578,0.0003185627,0.0000780787,0.00004650009,0.000064709566],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988168,0.000084355735,0.0002017491,0.00023746982,0.00026798918,0.00039165257],"domain_scores_gemma":[0.9992206,0.000049244387,0.00007548993,0.00030783392,0.00021290906,0.00013388462],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027423832,0.00016826713,0.00030821285,0.0011082841,0.0001678282,0.000023002303,0.00007172082,0.00009783629,0.000038559672],"category_scores_gemma":[0.00005177099,0.00012781082,0.000069304755,0.0019403703,0.00004365269,0.000081256396,0.000012163413,0.00017274315,0.000013335734],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000109965855,0.00051862356,0.9593926,0.000061749706,0.00029923592,0.0000042735137,0.001204967,0.0000324135,0.0071837716,0.0000046247937,0.00058254285,0.030605216],"study_design_scores_gemma":[0.005312861,0.0068785185,0.96610504,0.00024837095,0.00007395497,3.769339e-7,0.00043685705,0.00016394284,0.019618217,0.000028705295,0.00092018745,0.00021294518],"about_ca_topic_score_codex":0.004490064,"about_ca_topic_score_gemma":0.004658654,"teacher_disagreement_score":0.03039227,"about_ca_system_score_codex":0.00007931369,"about_ca_system_score_gemma":0.000098630655,"threshold_uncertainty_score":0.67876637},"labels":[],"label_agreement":null},{"id":"W4390913863","doi":"10.1007/s13300-023-01528-9","title":"Impact of Living with Stigma in Persons with Type 1 Diabetes: A Patient–Physician Perspective","year":2024,"lang":"en","type":"article","venue":"Diabetes Therapy","topic":"Obesity and Health Practices","field":"Health Professions","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Trillium Health Centre; University of Toronto","funders":"","keywords":"Medicine; Type 1 diabetes; Stigma (botany); Psychosocial; Quality of life (healthcare); Prejudice (legal term); Shame; Distress; Social stigma; Mental health; Psychiatry; Clinical psychology; Psychology; Diabetes mellitus; Social psychology; Human immunodeficiency virus (HIV); Family medicine; Nursing","score_opus":0.03303958857861965,"score_gpt":0.40331211672551653,"score_spread":0.3702725281468969,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390913863","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9884086,0.005752874,0.000002738396,0.00043305685,0.00015656887,0.0007879154,0.000041472398,0.00010290205,0.0043138736],"genre_scores_gemma":[0.99839115,0.0003721864,0.00013940781,0.00065718,0.00013802198,0.0001103057,0.0000051711304,0.00005513671,0.00013143304],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979011,0.0005295945,0.0002882347,0.00034677266,0.00024219169,0.00069209747],"domain_scores_gemma":[0.996835,0.0023681922,0.00019071664,0.00026701583,0.00022152443,0.000117566226],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044417006,0.0002284781,0.00041116364,0.00025415653,0.00030763418,0.00002431078,0.00013229069,0.0001297047,0.0005794173],"category_scores_gemma":[0.000121044766,0.00014669256,0.000073196315,0.00084215443,0.00010859644,0.00043350473,0.000028604827,0.00082527555,0.00010073826],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016152865,0.00036030667,0.92293376,0.0004915495,0.00035002665,0.000005212599,0.067966424,0.000032924658,0.00090915704,0.0003703127,0.00077258534,0.005646237],"study_design_scores_gemma":[0.00061559305,0.006594848,0.9510506,0.008902585,0.00005132902,2.0719088e-7,0.030003676,0.0006369464,0.00013009312,0.00023526177,0.0013762276,0.00040266538],"about_ca_topic_score_codex":0.0007045116,"about_ca_topic_score_gemma":0.00059923343,"teacher_disagreement_score":0.03796275,"about_ca_system_score_codex":0.0003268395,"about_ca_system_score_gemma":0.0008108272,"threshold_uncertainty_score":0.6344213},"labels":[],"label_agreement":null},{"id":"W4390945704","doi":"10.1007/s13300-023-01527-w","title":"Emotional, Psychological, and Social Well-being Experience of Long-Term Living with Type 1 Diabetes Mellitus: A Patient–Psychiatrist–Endocrinologist Perspective","year":2024,"lang":"en","type":"article","venue":"Diabetes Therapy","topic":"Diabetes Management and Research","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Mental Health Association; Trillium Health Centre; University of Toronto","funders":"","keywords":"Quality of life (healthcare); Medicine; Denial; Mental health; Anxiety; Distress; Perspective (graphical); Type 1 diabetes; Stressor; Psychiatry; Depression (economics); Anger; Clinical psychology; Psychology; Diabetes mellitus; Psychotherapist; Nursing","score_opus":0.022890172114547164,"score_gpt":0.329286928443934,"score_spread":0.3063967563293868,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390945704","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9768345,0.018661296,0.000011743315,0.00082280405,0.00021941445,0.00046896847,0.000004072858,0.00013245174,0.0028447902],"genre_scores_gemma":[0.9969967,0.001845614,0.00019887683,0.00036406686,0.00017262527,0.00005390132,0.000015244035,0.000036468067,0.0003165131],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982175,0.0000894493,0.00024398166,0.00052991154,0.00039187694,0.0005272326],"domain_scores_gemma":[0.99923486,0.000206735,0.00006984017,0.00022414971,0.00018280114,0.00008160883],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001649823,0.00023599573,0.00037249646,0.0002445696,0.00016051362,0.00011508918,0.00015159235,0.00008383597,0.00036200602],"category_scores_gemma":[0.000036310455,0.00016143055,0.00010795688,0.00048885477,0.00058699015,0.00015537052,0.00007947199,0.00027673208,0.000020705433],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013232518,0.0007760791,0.89869076,0.0005138467,0.0007099851,0.00003406597,0.006874382,0.0000012303344,0.0046011317,0.002194832,0.0007551821,0.08471619],"study_design_scores_gemma":[0.0015251214,0.005780012,0.9790809,0.0012380402,0.00013298706,0.0000031717775,0.0038220356,0.00023807818,0.004845601,0.0011585349,0.0016299528,0.0005455544],"about_ca_topic_score_codex":0.000003111263,"about_ca_topic_score_gemma":0.0000010628811,"teacher_disagreement_score":0.08417064,"about_ca_system_score_codex":0.000051035844,"about_ca_system_score_gemma":0.000029451123,"threshold_uncertainty_score":0.6582947},"labels":[],"label_agreement":null},{"id":"W4391716976","doi":"10.1007/s13300-024-01535-4","title":"Identifying Ontarians with Type 2 Diabetes Mellitus in Administrative Data: A Comparison of Two Case Definitions","year":2024,"lang":"en","type":"article","venue":"Diabetes Therapy","topic":"Medical Coding and Health Information","field":"Health Professions","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen's University","funders":"Novo Nordisk Canada","keywords":"Medicine; Cohort; Diabetes mellitus; Type 2 diabetes; Cohort study; Internal medicine; Pediatrics; Endocrinology","score_opus":0.5785092043281571,"score_gpt":0.5364634391774333,"score_spread":0.04204576515072378,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391716976","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99079925,0.0050278674,0.00021968487,0.00058673375,0.00056918146,0.0005808695,0.00014718474,0.00009800234,0.001971244],"genre_scores_gemma":[0.99719995,0.0005032244,0.0010947355,0.00057649106,0.00012000548,0.0001021681,0.0003442869,0.000019374293,0.000039765404],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99810183,0.00027821676,0.00072073156,0.00023429297,0.0002221411,0.00044277866],"domain_scores_gemma":[0.998116,0.0011143255,0.00016742735,0.00037560216,0.00010370139,0.00012295348],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010534484,0.00013988212,0.00035651482,0.0001852395,0.00030003174,0.000026491238,0.00017708233,0.00011132746,0.0003322691],"category_scores_gemma":[0.000105336716,0.000105613624,0.00002454363,0.0004912284,0.00008059471,0.00032803958,0.000043843553,0.0006928684,0.00009013761],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023249876,0.0005962375,0.74981165,0.0048566125,0.00041501934,0.00017472602,0.11087274,0.00005688754,0.0007205931,0.027419342,0.009425257,0.09541842],"study_design_scores_gemma":[0.02937234,0.012752781,0.19485772,0.048374172,0.00083317107,0.00005866641,0.13075037,0.23810878,0.008941623,0.047091406,0.2842252,0.0046337666],"about_ca_topic_score_codex":0.00043753724,"about_ca_topic_score_gemma":0.0032440897,"teacher_disagreement_score":0.55495393,"about_ca_system_score_codex":0.000088927314,"about_ca_system_score_gemma":0.0005669882,"threshold_uncertainty_score":0.43067986},"labels":[],"label_agreement":null},{"id":"W4393114796","doi":"10.1007/s13300-024-01549-y","title":"Validity of Montreal Cognitive Assessment to Detect Cognitive Impairment in Individuals with Type 2 Diabetes","year":2024,"lang":"en","type":"article","venue":"Diabetes Therapy","topic":"Dementia and Cognitive Impairment Research","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Indian Council of Medical Research","keywords":"Montreal Cognitive Assessment; Medicine; Cognitive impairment; Type 2 diabetes; Diabetes mellitus; Cognition; Gerontology; Psychiatry; Endocrinology","score_opus":0.02273430786966418,"score_gpt":0.3412973756145462,"score_spread":0.318563067744882,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393114796","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99377793,0.0011777984,0.000078391706,0.0002812325,0.00009335611,0.0022459337,0.00013762568,0.00008169868,0.0021260409],"genre_scores_gemma":[0.99790967,0.00032724897,0.00024980534,0.00060400396,0.00007642239,0.0004758772,0.00013926123,0.00005287012,0.00016482479],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974232,0.00025834152,0.0003602293,0.000531325,0.0007522587,0.00067469524],"domain_scores_gemma":[0.9984109,0.0007261142,0.00006089318,0.00016814063,0.00039583753,0.0002381265],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009183652,0.00030680562,0.00055010646,0.0005488733,0.000047969374,0.000075174044,0.00011091205,0.000087771165,0.0005242494],"category_scores_gemma":[0.00008945516,0.00022522466,0.00012142894,0.0010418259,0.00014409558,0.00014354245,0.00006886141,0.00032843873,0.00005615099],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003161535,0.0006185034,0.8880688,0.00018201568,0.00069846946,0.000036555422,0.0006775294,8.3959003e-7,0.0061525633,0.0000067880624,0.00014536758,0.10309644],"study_design_scores_gemma":[0.0035865507,0.0101674935,0.8831058,0.00162492,0.00015957336,0.0000013544227,0.0004671762,0.00009859666,0.10016148,0.00021378124,0.00017702857,0.00023625403],"about_ca_topic_score_codex":0.00003333151,"about_ca_topic_score_gemma":0.00002463255,"teacher_disagreement_score":0.10286018,"about_ca_system_score_codex":0.00011605459,"about_ca_system_score_gemma":0.00033339477,"threshold_uncertainty_score":0.91843957},"labels":[],"label_agreement":null},{"id":"W4399544780","doi":"10.1007/s13300-024-01603-9","title":"Perspectives and Behaviors of People with Diabetes toward Time in Range and Glucose Control in Diabetes Management: An Online Survey","year":2024,"lang":"en","type":"article","venue":"Diabetes Therapy","topic":"Diabetes Management and Education","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Trillium Health Centre","funders":"Novo Nordisk","keywords":"Diabetes mellitus; Medicine; Diabetes management; Diabetes control; Control (management); Gerontology; Endocrinology; Type 2 diabetes; Artificial intelligence; Computer science","score_opus":0.01734584637604032,"score_gpt":0.267933354979457,"score_spread":0.25058750860341666,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399544780","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9844932,0.013662654,0.0000012990764,0.0005807488,0.00006593958,0.0009605827,0.00007057725,0.00006787146,0.000097108685],"genre_scores_gemma":[0.9978981,0.0012368875,0.00015233764,0.00019828019,0.00004726661,0.00011724244,0.00016914956,0.000052450214,0.00012826051],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99838465,0.00015437823,0.00030945477,0.00049992284,0.00021166513,0.0004399067],"domain_scores_gemma":[0.9992925,0.00022112908,0.000062673615,0.0002538042,0.000060278195,0.00010964378],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00075747765,0.00027217838,0.0005806732,0.0006284879,0.000026032028,0.00007882209,0.00010113421,0.00007660983,0.00007540055],"category_scores_gemma":[0.000025233527,0.00022353258,0.00004257857,0.0006687946,0.00015232319,0.0003441472,0.00003276518,0.00016702506,0.0000036923147],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001062084,0.00073937257,0.95199096,0.0003967305,0.00020086425,0.0000043589966,0.0036511938,0.0000025120096,0.0031915542,0.000050678376,0.000037556983,0.039628036],"study_design_scores_gemma":[0.0032756594,0.0009101667,0.99071014,0.00043478364,0.000111589005,1.02346284e-7,0.0012074735,0.0023167091,0.0005922683,0.00012475738,0.00007420097,0.00024212727],"about_ca_topic_score_codex":0.000054834432,"about_ca_topic_score_gemma":0.00014478035,"teacher_disagreement_score":0.03938591,"about_ca_system_score_codex":0.00005409304,"about_ca_system_score_gemma":0.000023826582,"threshold_uncertainty_score":0.9115394},"labels":[],"label_agreement":null},{"id":"W4400789217","doi":"10.1007/s13300-024-01606-6","title":"Epidemiology and Burden of Peripheral Artery Disease in People With Type 2 Diabetes: A Systematic Literature Review","year":2024,"lang":"en","type":"review","venue":"Diabetes Therapy","topic":"Peripheral Artery Disease Management","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Novo Nordisk","keywords":"Medicine; Epidemiology; Diabetes mellitus; Type 2 diabetes; Disease; Systematic review; Arterial disease; Intensive care medicine; MEDLINE; Internal medicine; Vascular disease; Endocrinology","score_opus":0.0265531670890875,"score_gpt":0.31857271021602207,"score_spread":0.29201954312693457,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400789217","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0031917093,0.99128324,4.1582945e-7,0.0004005625,0.00014311599,0.004788484,0.00007851419,0.00006835037,0.000045620658],"genre_scores_gemma":[0.0003824315,0.9955523,0.000053893953,0.0015746846,0.00016084142,0.001359498,0.00042775678,0.0001161743,0.00037240848],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9963831,0.00079355406,0.001274042,0.00075071404,0.00025091856,0.0005476822],"domain_scores_gemma":[0.9979832,0.00029627088,0.00041989714,0.00088618137,0.00009634841,0.00031806543],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007963106,0.00074140006,0.0054882304,0.0003439188,0.000024118259,0.000028014558,0.00022870762,0.00018139477,0.00008658778],"category_scores_gemma":[0.00019812508,0.00042397482,0.00051771844,0.0010200301,0.00012120942,0.00009036309,0.000085288506,0.0004544682,0.000027352045],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000031089585,0.000102027094,0.0027914287,0.94212997,0.0011415913,0.000094366806,0.00018129934,6.495033e-7,6.0087353e-7,0.000023046803,0.000638828,0.052865103],"study_design_scores_gemma":[0.0004439614,0.00045312455,0.0006508393,0.9058013,0.00423652,0.00000881964,0.000010068977,0.00011574424,4.8750607e-8,0.000046026027,0.087824516,0.00040901304],"about_ca_topic_score_codex":0.000002099312,"about_ca_topic_score_gemma":0.0000021782075,"teacher_disagreement_score":0.08718569,"about_ca_system_score_codex":0.00013806025,"about_ca_system_score_gemma":0.00019826228,"threshold_uncertainty_score":0.9998212},"labels":[],"label_agreement":null},{"id":"W4401163838","doi":"10.1007/s13300-024-01628-0","title":"Medication-Induced Hyperglycemia and Diabetes Mellitus: A Review of Current Literature and Practical Management Strategies","year":2024,"lang":"en","type":"review","venue":"Diabetes Therapy","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; University of British Columbia","funders":"AstraZeneca; Amgen","keywords":"Medicine; Diabetes mellitus; Intensive care medicine; Endocrinology","score_opus":0.04936297382883068,"score_gpt":0.383220159848608,"score_spread":0.3338571860197773,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401163838","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005047028,0.99449295,9.558339e-7,0.0005767013,0.0003405176,0.0029632712,0.000049602837,0.00009639493,0.00097488257],"genre_scores_gemma":[0.00008653982,0.9972889,0.00030550014,0.0004153713,0.00017608759,0.0008311831,0.0006380226,0.00009077693,0.00016763376],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99725777,0.00016421787,0.0008541244,0.00078976864,0.00048683627,0.0004472902],"domain_scores_gemma":[0.99842614,0.00022274665,0.00037360578,0.00065801735,0.00009809715,0.00022139489],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000535353,0.0007438691,0.0024288546,0.00039811438,0.000048323567,0.00015607235,0.00012993191,0.00023180731,0.000056205023],"category_scores_gemma":[0.000042693304,0.00047646643,0.00041482123,0.0005607143,0.00015188426,0.00019047593,0.00016869158,0.0005091112,0.000026448262],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000042480983,0.00016452257,0.000021340447,0.31562892,0.0019301979,0.000017553368,0.000051812312,8.67088e-10,0.0000017752635,0.0019477471,0.002630408,0.67760146],"study_design_scores_gemma":[0.00047549614,0.00032113996,0.000028841687,0.27211574,0.006277476,0.0000038590742,0.000017483473,0.0000022364716,0.0000064123956,0.00042840999,0.7200363,0.00028660335],"about_ca_topic_score_codex":3.7879116e-7,"about_ca_topic_score_gemma":1.4730307e-7,"teacher_disagreement_score":0.7174059,"about_ca_system_score_codex":0.00007085916,"about_ca_system_score_gemma":0.00015576684,"threshold_uncertainty_score":0.9997687},"labels":[],"label_agreement":null},{"id":"W4404202498","doi":"10.1007/s13300-024-01659-7","title":"Cardiovascular, Metabolic, and Safety Outcomes with Semaglutide by Baseline Age: Post Hoc Analysis of SUSTAIN 6 and PIONEER 6","year":2024,"lang":"en","type":"article","venue":"Diabetes Therapy","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ted Rogers Centre for Heart Research; University of Toronto","funders":"Novo Nordisk","keywords":"Semaglutide; Post-hoc analysis; Medicine; Baseline (sea); Diabetes mellitus; Post hoc; Internal medicine; Type 2 diabetes; Endocrinology; Liraglutide","score_opus":0.005565111311902527,"score_gpt":0.23040575488444723,"score_spread":0.2248406435725447,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404202498","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.87818915,0.119771324,0.00011351993,0.0010737262,0.00003045102,0.00044810784,0.000095342584,0.000072075,0.00020630483],"genre_scores_gemma":[0.9861527,0.010594753,0.00053759007,0.00074962666,0.000025934261,0.00004644834,0.00033731762,0.000039883205,0.0015157345],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9987932,0.000065764405,0.00022725819,0.00036089332,0.0002881978,0.0002646948],"domain_scores_gemma":[0.99927014,0.00014756504,0.000035042434,0.00035891164,0.00007730857,0.00011103007],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004641511,0.00024028745,0.0008989897,0.00038638467,0.00004080207,0.000049100265,0.000047087018,0.000048155405,0.0000624647],"category_scores_gemma":[0.000017122195,0.00015201214,0.0003056274,0.00063662126,0.000112316135,0.00007534215,0.00003338865,0.000075022486,0.0000016657497],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034936896,0.00036087053,0.38353762,0.00042415436,0.13363431,0.00009447752,0.0008100037,0.00005679197,0.0026888957,0.0009254469,0.0011863938,0.47593167],"study_design_scores_gemma":[0.0077755502,0.0015997638,0.677185,0.00017489192,0.035737913,0.0000017156646,0.00051124516,0.0021900772,0.0043525947,0.00008416783,0.2697599,0.00062716077],"about_ca_topic_score_codex":0.000053680084,"about_ca_topic_score_gemma":0.000013722834,"teacher_disagreement_score":0.4753045,"about_ca_system_score_codex":0.000020599244,"about_ca_system_score_gemma":0.000019663557,"threshold_uncertainty_score":0.61988753},"labels":[],"label_agreement":null},{"id":"W4404338793","doi":"10.1007/s13300-024-01668-6","title":"Oral Semaglutide Use in Type 2 Diabetes: A Pooled Analysis of Clinical and Patient-Reported Outcomes from Seven PIONEER REAL Prospective Real-World Studies","year":2024,"lang":"en","type":"article","venue":"Diabetes Therapy","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia","funders":"Novo Nordisk","keywords":"Semaglutide; Medicine; Type 2 diabetes; Diabetes mellitus; Pooled analysis; Prospective cohort study; Meta-analysis; Pediatrics; Internal medicine; Endocrinology","score_opus":0.061546688346997835,"score_gpt":0.3677193614407986,"score_spread":0.30617267309380075,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404338793","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99264014,0.0053188032,5.4199455e-7,0.00035905308,0.00033108643,0.00086598325,0.000054291548,0.00013736733,0.00029271882],"genre_scores_gemma":[0.9945446,0.0035991366,0.00040898548,0.0004362012,0.00004109463,0.000108803346,0.00015758118,0.000042521177,0.00066104415],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99755585,0.00015469131,0.0009569924,0.0006286269,0.00033153628,0.00037232475],"domain_scores_gemma":[0.99819183,0.00086011854,0.0001959926,0.0004617585,0.00017364064,0.000116681025],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044269965,0.00032454845,0.0016034266,0.0007648641,0.000032280765,0.000050301787,0.00007258848,0.00009281889,0.000073479045],"category_scores_gemma":[0.00021269229,0.00023024173,0.00035250478,0.0015645949,0.00018750664,0.00016018939,0.000084437735,0.00018200674,0.000006589209],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017189462,0.0004991817,0.92608356,0.000050097344,0.034445494,0.000045787736,0.0012266247,0.000009873729,0.00033100296,0.00008894696,0.0004494737,0.036598045],"study_design_scores_gemma":[0.0023446023,0.00070120057,0.98861665,0.00022680867,0.004933406,2.6371856e-8,0.00024542565,0.00091349066,0.0007373542,0.00043131725,0.00063516764,0.00021458189],"about_ca_topic_score_codex":0.00049952645,"about_ca_topic_score_gemma":0.00083898625,"teacher_disagreement_score":0.06253304,"about_ca_system_score_codex":0.00009203711,"about_ca_system_score_gemma":0.000053504802,"threshold_uncertainty_score":0.9388985},"labels":[],"label_agreement":null},{"id":"W4405458940","doi":"10.1007/s13300-024-01677-5","title":"Cost-Effectiveness of FreeStyle Libre for Glucose Self-Management Among People with Diabetes Mellitus: A Canadian Private Payer Perspective","year":2024,"lang":"en","type":"article","venue":"Diabetes Therapy","topic":"Diabetes Management and Research","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Abbott (Canada); EVERSANA (Canada); Western University","funders":"Abbott Diabetes Care","keywords":"Medicine; Glycated hemoglobin; Diabetes mellitus; Type 1 diabetes; Type 2 Diabetes Mellitus; Hypoglycemia; Insulin; Blood Glucose Self-Monitoring; Diabetic ketoacidosis; Intensive care medicine; Type 2 diabetes; Internal medicine; Endocrinology; Continuous glucose monitoring","score_opus":0.015296523712522013,"score_gpt":0.28376256865933874,"score_spread":0.26846604494681675,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405458940","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98098344,0.0083066905,0.000092670714,0.0005930008,0.0001934583,0.0059302966,0.00006888106,0.00024961063,0.003581964],"genre_scores_gemma":[0.9954639,0.0006269588,0.0008069764,0.00017135167,0.00012743646,0.0019091549,0.00013048286,0.00012995451,0.00063376117],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975067,0.0001378681,0.00026407515,0.00066231034,0.0004529357,0.0009761415],"domain_scores_gemma":[0.99831825,0.0004506899,0.00006241459,0.00053433416,0.00028363042,0.0003506994],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00088172324,0.00036682427,0.0006165321,0.0006466605,0.00013458956,0.00015567215,0.00029823845,0.00011850508,0.000109078755],"category_scores_gemma":[0.00003084708,0.0002660113,0.00024012981,0.0009697665,0.00016722851,0.0002774785,0.0000681594,0.00023460195,0.000024928278],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00084294105,0.0013771362,0.83963233,0.010197702,0.011503052,0.00008129773,0.0038231388,0.00011709368,0.005579516,0.019084955,0.0022548414,0.105506025],"study_design_scores_gemma":[0.010658712,0.0050874255,0.800158,0.0040671155,0.0010058286,4.706665e-7,0.0014008122,0.008847218,0.08414729,0.0045497906,0.07885262,0.0012246857],"about_ca_topic_score_codex":0.0005803423,"about_ca_topic_score_gemma":0.0010963278,"teacher_disagreement_score":0.104281336,"about_ca_system_score_codex":0.00036947825,"about_ca_system_score_gemma":0.00019350703,"threshold_uncertainty_score":0.9999792},"labels":[],"label_agreement":null},{"id":"W4405466175","doi":"10.1007/s13300-024-01671-x","title":"Clinical Profile and Treatment Adherence in Patients with Type 2 Diabetes and Chronic Kidney Disease Who Initiate an SGLT2 Inhibitor: A Multi-cohort Study","year":2024,"lang":"en","type":"article","venue":"Diabetes Therapy","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Bayer","keywords":"Medicine; Type 2 diabetes; Diabetes mellitus; Kidney disease; Cohort; Disease; Internal medicine; Cohort study; Intensive care medicine; Endocrinology","score_opus":0.02515344726231022,"score_gpt":0.3114057257762158,"score_spread":0.28625227851390556,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405466175","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9912429,0.0047083343,3.370094e-7,0.000060774557,0.00018063332,0.0035574306,0.00004425826,0.00012836314,0.00007695452],"genre_scores_gemma":[0.9969918,0.0012751184,0.00011043345,0.0003028017,0.000117577896,0.00060326286,0.0002693148,0.00006027425,0.00026937423],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99810994,0.00013595494,0.00034384284,0.00074489275,0.0002381927,0.00042719193],"domain_scores_gemma":[0.9989645,0.00007843029,0.000055276185,0.00038559965,0.00005711176,0.00045907265],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025218842,0.0003604808,0.00056141015,0.00017886491,0.00005874715,0.000118631964,0.000065206754,0.000063260275,0.00006719825],"category_scores_gemma":[0.00002577172,0.00023886639,0.000054925516,0.00025134694,0.00013703568,0.00026762066,0.0000511364,0.00013403788,0.000016743104],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024830937,0.0036696063,0.88754445,0.00010426587,0.0007306087,0.000027235707,0.00038392292,3.1875055e-7,0.000025277028,0.0000068178556,0.000084941785,0.107174255],"study_design_scores_gemma":[0.011162863,0.018259544,0.967832,0.0004525859,0.00035411306,3.6375038e-8,0.00005248513,0.000703008,0.00010271123,0.000018445066,0.0007992153,0.00026293815],"about_ca_topic_score_codex":0.0000144077885,"about_ca_topic_score_gemma":0.000029073357,"teacher_disagreement_score":0.10691132,"about_ca_system_score_codex":0.00013483278,"about_ca_system_score_gemma":0.00014437243,"threshold_uncertainty_score":0.9740689},"labels":[],"label_agreement":null},{"id":"W4405657525","doi":"10.1007/s13300-024-01674-8","title":"A Bioequivalence Study of Two Formulations of Oral Semaglutide in Healthy Participants","year":2024,"lang":"en","type":"article","venue":"Diabetes Therapy","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Altasciences (Canada)","funders":"Novo Nordisk","keywords":"Bioequivalence; Semaglutide; Medicine; Cmax; Pharmacokinetics; Crossover study; Confidence interval; Dosing; Pharmacology; Oral administration; Internal medicine; Type 2 diabetes; Diabetes mellitus; Endocrinology; Placebo; Alternative medicine","score_opus":0.07649554360568715,"score_gpt":0.3842856745036573,"score_spread":0.30779013089797014,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405657525","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99626625,0.0020676379,0.00000882587,0.0002579088,0.000091465874,0.0009346229,0.000007521515,0.000043978278,0.00032177722],"genre_scores_gemma":[0.9992122,0.00014482584,0.00029745887,0.000119845725,0.000014549879,0.00010164712,0.000008657091,0.000016178137,0.000084614534],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989576,0.000042279924,0.00034645986,0.00018749939,0.00018825568,0.00027791742],"domain_scores_gemma":[0.99953496,0.00008124232,0.000052524672,0.00024141587,0.000034344066,0.000055529326],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026523013,0.000112155336,0.00033626315,0.00025169554,0.000014831899,0.0000078627745,0.00006390412,0.000020772131,0.000062113155],"category_scores_gemma":[0.000012613774,0.000086339605,0.00006588342,0.00045947367,0.000038886756,0.0000644445,0.000023962371,0.00005670564,0.000007869462],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014133351,0.0027120435,0.9304507,0.0002533035,0.00045589134,0.000010246867,0.0023182663,0.000032593798,0.0045402143,0.0015459547,0.000076509925,0.057462953],"study_design_scores_gemma":[0.012679758,0.012322709,0.9484655,0.00065929734,0.000370659,2.2400913e-7,0.0006131459,0.0046040732,0.01607028,0.0027962057,0.0011714668,0.00024667577],"about_ca_topic_score_codex":0.00012641557,"about_ca_topic_score_gemma":0.00009742866,"teacher_disagreement_score":0.05721628,"about_ca_system_score_codex":0.000037351736,"about_ca_system_score_gemma":0.00003900987,"threshold_uncertainty_score":0.3520827},"labels":[],"label_agreement":null},{"id":"W4408621302","doi":"10.1007/s13300-025-01717-8","title":"Clinical Profile and Treatment Patterns in Individuals with Type 2 Diabetes and Chronic Kidney Disease Who Initiate a GLP-1 Receptor Agonist: A Multinational Cohort Study","year":2025,"lang":"en","type":"article","venue":"Diabetes Therapy","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Bayer","keywords":"Medicine; Type 2 diabetes; Diabetes mellitus; Agonist; Kidney disease; Disease; Cohort; Internal medicine; Receptor; Endocrinology","score_opus":0.017642522699609454,"score_gpt":0.31012728479725227,"score_spread":0.2924847620976428,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408621302","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99299246,0.0021296872,0.0000010594607,0.0007045031,0.00010487175,0.0036002228,0.00011350108,0.00006285322,0.00029081796],"genre_scores_gemma":[0.9936619,0.0022932296,0.0001351353,0.0011936745,0.00008164274,0.0012061356,0.00048612914,0.000032328302,0.0009098615],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982337,0.00016390908,0.0003778692,0.00060097955,0.0002339228,0.0003896261],"domain_scores_gemma":[0.9990518,0.00018781306,0.000099278404,0.00031781857,0.0000714396,0.0002718229],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037032668,0.0003244479,0.00062082126,0.00023997865,0.0000886815,0.00007981605,0.00007470284,0.00006593107,0.00013865373],"category_scores_gemma":[0.00006073876,0.00023055669,0.00005944353,0.00026889634,0.00013478208,0.00011427217,0.000070015696,0.00011759252,0.000008230818],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015779931,0.0024390935,0.93045634,0.00009567473,0.0014650202,0.000010238734,0.0002497213,4.239622e-7,0.000032584332,0.00003701486,0.0003542262,0.06470184],"study_design_scores_gemma":[0.012904864,0.004252058,0.9766741,0.00041049905,0.00037220272,5.54058e-8,0.00007369383,0.00017799388,0.00021077477,0.000049551512,0.0046630176,0.00021120635],"about_ca_topic_score_codex":0.000018424207,"about_ca_topic_score_gemma":0.00002962283,"teacher_disagreement_score":0.06449063,"about_ca_system_score_codex":0.00016353404,"about_ca_system_score_gemma":0.00021852994,"threshold_uncertainty_score":0.9401829},"labels":[],"label_agreement":null},{"id":"W4408921665","doi":"10.1007/s13300-025-01725-8","title":"Systematic Literature Review of the Impact of Type 2 Diabetes and Heart Failure Guideline Adherence on Clinical and Economic Outcomes","year":2025,"lang":"en","type":"review","venue":"Diabetes Therapy","topic":"Medication Adherence and Compliance","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; MEDLINE; Intensive care medicine; Guideline; Disease management; Type 2 diabetes; Systematic review; Diabetes mellitus; Clinical trial; Disease; Internal medicine; Pathology","score_opus":0.05839507894475807,"score_gpt":0.4296025219781489,"score_spread":0.3712074430333908,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408921665","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.003290528,0.9938928,1.4869259e-7,0.00037934005,0.00016530951,0.0021177446,0.00007016346,0.0000110676165,0.00007291392],"genre_scores_gemma":[0.00018403235,0.997756,0.00007951045,0.0014261614,0.000055547163,0.00010815756,0.00005155942,0.000018626422,0.00032042965],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9973149,0.00042621742,0.0015900567,0.00033390295,0.00016632785,0.00016860274],"domain_scores_gemma":[0.99706584,0.000922788,0.00088357576,0.0008566663,0.00017430731,0.000096796975],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009265843,0.00035145966,0.0036788767,0.000092249335,0.000025575366,0.000015122682,0.0002594388,0.00022511843,0.00017036905],"category_scores_gemma":[0.00076653657,0.00016567683,0.0006974613,0.0002886498,0.00018000693,0.000032285036,0.000052185766,0.0003599044,0.000021148986],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000057400002,0.0000798513,0.023185316,0.8538445,0.0009454523,2.6091158e-7,0.000013112977,4.0989065e-8,0.000002455061,0.000040379648,0.023793107,0.09808974],"study_design_scores_gemma":[0.00039313568,0.00057326804,0.002389104,0.9472292,0.0005632203,0.0000021665794,0.0000030246874,0.000007248168,0.0000038397766,0.000035143355,0.048654597,0.00014602639],"about_ca_topic_score_codex":0.0000014444975,"about_ca_topic_score_gemma":1.9025765e-7,"teacher_disagreement_score":0.097943716,"about_ca_system_score_codex":0.000024270854,"about_ca_system_score_gemma":0.00044179676,"threshold_uncertainty_score":0.67561054},"labels":[],"label_agreement":null},{"id":"W4411043752","doi":"10.1007/s13300-025-01750-7","title":"Outcomes in New User Cohorts of SGLT2 Inhibitors or GLP-1 Receptor Agonists with Type 2 Diabetes and Chronic Kidney Disease","year":2025,"lang":"en","type":"article","venue":"Diabetes Therapy","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Bayer","keywords":"Medicine; Kidney disease; Internal medicine; Renal function; Type 2 diabetes; Diabetes mellitus; Incidence (geometry); Heart failure; Endocrinology","score_opus":0.008517939849199086,"score_gpt":0.2554512744432463,"score_spread":0.2469333345940472,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411043752","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9905417,0.00548005,0.0000010548347,0.0021048961,0.00025364794,0.0010786274,0.000016498017,0.00006729315,0.00045626122],"genre_scores_gemma":[0.9836445,0.0017403305,0.00026207633,0.0021308677,0.00007789418,0.00009076309,0.00012775917,0.000043626653,0.011882174],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99864906,0.00004070682,0.0003071867,0.0003749042,0.00021586279,0.00041230756],"domain_scores_gemma":[0.9990478,0.000105250736,0.00009445468,0.00039863202,0.000058000755,0.00029582766],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000120784964,0.00029846944,0.00065117644,0.00027020782,0.000039498616,0.000033743472,0.00010059083,0.00006859327,0.000298591],"category_scores_gemma":[0.0000755792,0.0001925962,0.00007731282,0.00048179537,0.00012950652,0.00011965127,0.00005494023,0.00009923607,0.000011862071],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040148318,0.00044024407,0.95692617,0.00030445066,0.0007631242,0.0000073557526,0.00009250031,0.0000020457153,0.0021969406,0.00012449888,0.008811671,0.029929498],"study_design_scores_gemma":[0.010003109,0.0019250944,0.8843657,0.0013210945,0.0003395416,5.21756e-8,0.00003355239,0.000043557062,0.02394282,0.00016327103,0.07751591,0.0003463029],"about_ca_topic_score_codex":0.000017646364,"about_ca_topic_score_gemma":0.000022377437,"teacher_disagreement_score":0.07256049,"about_ca_system_score_codex":0.00011742741,"about_ca_system_score_gemma":0.00045663453,"threshold_uncertainty_score":0.78538454},"labels":[],"label_agreement":null},{"id":"W4412512272","doi":"10.1007/s13300-025-01772-1","title":"Real-World Effectiveness of My Dose Coach™-Assisted Basal Insulin Titration in People with Type 2 Diabetes in Saudi Arabia and Kuwait","year":2025,"lang":"en","type":"article","venue":"Diabetes Therapy","topic":"Mobile Health and mHealth Applications","field":"Health Professions","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Sanofi","keywords":"Medicine; Basal insulin; Type 2 diabetes; Diabetes mellitus; Basal (medicine); Insulin; Internal medicine; Endocrinology","score_opus":0.02097535155161321,"score_gpt":0.3613597529609785,"score_spread":0.34038440140936527,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412512272","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99226433,0.0013176316,0.000008926907,0.0005320244,0.00015926454,0.0035765315,0.00002128974,0.00004738843,0.0020726232],"genre_scores_gemma":[0.992248,0.0021977636,0.00017403938,0.0008771402,0.00003230107,0.0042392593,0.00009766106,0.000024519339,0.00010932852],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973334,0.00094668125,0.0006576873,0.00036827516,0.00013667092,0.00055727334],"domain_scores_gemma":[0.9973762,0.0017791428,0.00022608272,0.00033676834,0.00015959503,0.00012223037],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014382679,0.00018911602,0.0005535197,0.00044093255,0.00019121294,0.000007206359,0.00012521568,0.00017944406,0.000044677927],"category_scores_gemma":[0.00009526931,0.00016217564,0.000024812794,0.0016030911,0.00007809665,0.00009534193,0.000031260446,0.00044977755,0.00000866057],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044336924,0.00023402149,0.975576,0.0014062972,0.000017800941,2.4312183e-7,0.00031288582,0.000015716665,0.0037882137,0.0021098703,0.00013577561,0.015959848],"study_design_scores_gemma":[0.0035455266,0.00022633235,0.99091476,0.00094344583,0.000008056502,1.4794007e-8,0.00009197375,0.0004021782,0.00095112826,0.0011777609,0.0016138462,0.0001249729],"about_ca_topic_score_codex":0.0013137076,"about_ca_topic_score_gemma":0.011728301,"teacher_disagreement_score":0.015834875,"about_ca_system_score_codex":0.00019873922,"about_ca_system_score_gemma":0.0007068179,"threshold_uncertainty_score":0.661333},"labels":[],"label_agreement":null},{"id":"W4413335991","doi":"10.1007/s13300-025-01779-8","title":"Quantifying Patient Preferences for Basal Insulin Treatments in Adults Living with Type 2 Diabetes: A Discrete Choice Experiment in Canada, Spain, France, and Japan","year":2025,"lang":"en","type":"article","venue":"Diabetes Therapy","topic":"Economic and Environmental Valuation","field":"Economics, Econometrics and Finance","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Novo Nordisk","keywords":"Medicine; Type 2 diabetes; Basal insulin; Diabetes mellitus; Basal (medicine); Gerontology; Endocrinology","score_opus":0.03772920654805889,"score_gpt":0.2218588422073667,"score_spread":0.18412963565930782,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413335991","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99094015,0.007998335,0.000008809862,0.00006673403,0.000125388,0.0005332414,0.00004469543,0.0000055604582,0.00027706698],"genre_scores_gemma":[0.9983434,0.0007411943,0.0001749307,0.0003526579,0.000011200101,0.0003047432,0.000021688604,0.0000143308835,0.00003586349],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99897206,0.000019440706,0.00036151774,0.0003530212,0.000025131303,0.0002688316],"domain_scores_gemma":[0.9995423,0.00015142917,0.00013396882,0.00013198846,0.000005965076,0.000034323246],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015344861,0.00015245168,0.00030234296,0.00012870687,0.000048194168,0.000027245746,0.00007886388,0.00004233132,0.000038945167],"category_scores_gemma":[0.000023823632,0.00014865004,0.00002142114,0.00012994326,0.00002555106,0.00014471942,0.000021397978,0.000058762864,0.0000027263366],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000020030384,0.00006931956,0.98747087,0.000026982078,0.000044988752,6.865056e-8,0.0007522629,0.00018221699,0.00002862706,0.000120536024,0.000012236157,0.011271894],"study_design_scores_gemma":[0.0014124527,0.00025918568,0.99190986,0.00022641325,0.000002066785,6.6709602e-9,0.0004036895,0.00473646,0.000360797,0.0003054819,0.00021031032,0.00017328754],"about_ca_topic_score_codex":0.05497324,"about_ca_topic_score_gemma":0.12096092,"teacher_disagreement_score":0.065987684,"about_ca_system_score_codex":0.0003308389,"about_ca_system_score_gemma":0.000048223974,"threshold_uncertainty_score":0.95131975},"labels":[],"label_agreement":null},{"id":"W4413981095","doi":"10.1007/s13300-025-01783-y","title":"Perceptions of the Benefits and Risks of Novel Therapies for Type 1 Diabetes: A Qualitative Study","year":2025,"lang":"en","type":"article","venue":"Diabetes Therapy","topic":"Pancreatic function and diabetes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Type 2 diabetes; Disease; Diabetes mellitus; Type 1 diabetes; Qualitative research; MEDLINE; Family medicine; Gerontology; Pathology","score_opus":0.11153474332770745,"score_gpt":0.4020986712141507,"score_spread":0.29056392788644325,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413981095","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929699,0.0049372856,0.000021977989,0.00045944867,0.0001515656,0.0010834424,0.000084499065,0.000020460518,0.00027145693],"genre_scores_gemma":[0.9984178,0.00023783975,0.00035075264,0.0005726216,0.000023304268,0.00012601478,0.00000829749,0.000013332289,0.00025005397],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999157,0.00009032038,0.0002803694,0.00017474483,0.00013705557,0.00016052483],"domain_scores_gemma":[0.9985344,0.00073581294,0.000116891206,0.0002967379,0.00028302794,0.000033159075],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037977006,0.00013442773,0.00041970314,0.00011079997,0.00008321468,0.000007840109,0.00008843305,0.000057240373,0.000042271866],"category_scores_gemma":[0.0002423645,0.000083867104,0.00011731512,0.00034944038,0.00019586347,0.000035997124,0.00002441367,0.00007201123,4.4990782e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002152194,0.0016387695,0.78587776,0.00018081487,0.0012403687,1.4274376e-8,0.027493773,0.0000072809326,0.15824576,0.0013283704,0.000302695,0.02346917],"study_design_scores_gemma":[0.007846047,0.0025338882,0.9048402,0.00039558974,0.00033270457,5.6323373e-8,0.038088355,0.00030316762,0.044015244,0.00082979613,0.00065557455,0.00015939224],"about_ca_topic_score_codex":0.000013363461,"about_ca_topic_score_gemma":0.0000027248482,"teacher_disagreement_score":0.11896242,"about_ca_system_score_codex":0.000013409453,"about_ca_system_score_gemma":0.00006016604,"threshold_uncertainty_score":0.3420001},"labels":[],"label_agreement":null},{"id":"W4414361910","doi":"10.1007/s13300-025-01796-7","title":"Pillar Risk-Based Treatment for Chronic Kidney Disease in People With Type 2 Diabetes: A Narrative Review","year":2025,"lang":"en","type":"article","venue":"Diabetes Therapy","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; Trillium Health Centre; University of Toronto","funders":"Bayer","keywords":"Kidney disease; Tolerability; Context (archaeology); Disease; Narrative review; Diabetes mellitus; Type 2 diabetes","score_opus":0.011106669528985659,"score_gpt":0.2817078758975569,"score_spread":0.27060120636857127,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414361910","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8913262,0.09687887,0.000026091466,0.0052233646,0.00016068823,0.0056616333,0.00007711408,0.00012585444,0.0005201994],"genre_scores_gemma":[0.92278725,0.0510384,0.0005950214,0.015685394,0.00012476812,0.0056387405,0.0012850732,0.000092792034,0.0027525625],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984168,0.000091314476,0.00029119017,0.0004900271,0.0001747417,0.0005359282],"domain_scores_gemma":[0.99879426,0.00016376073,0.0001224079,0.00056405674,0.000120548946,0.00023498396],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00019508605,0.00038119394,0.00074150116,0.00021614209,0.00010455112,0.000027226442,0.00011221,0.00005107844,0.00014030712],"category_scores_gemma":[0.000097948,0.0002559337,0.00020483666,0.0006919744,0.00006222593,0.00007060313,0.000015152295,0.000079067264,0.000015655753],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009089641,0.0021266323,0.9042327,0.0031805001,0.0018859426,0.000009192781,0.00035086586,0.000067701476,0.00029091683,0.00010680364,0.011983703,0.07485612],"study_design_scores_gemma":[0.058338575,0.021973573,0.29612374,0.021721197,0.003915065,6.7914556e-8,0.0001283068,0.005215933,0.010047454,0.0005722214,0.5806422,0.0013216166],"about_ca_topic_score_codex":0.0000147889905,"about_ca_topic_score_gemma":0.000047888643,"teacher_disagreement_score":0.60810894,"about_ca_system_score_codex":0.00055102515,"about_ca_system_score_gemma":0.0006203587,"threshold_uncertainty_score":0.9999893},"labels":[],"label_agreement":null},{"id":"W4414523792","doi":"10.1007/s13300-025-01787-8","title":"Risk of Progression and Costs of Care for Patients with Type 2 Diabetes and Chronic Kidney Disease","year":2025,"lang":"en","type":"article","venue":"Diabetes Therapy","topic":"Chronic Kidney Disease and Diabetes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Seven Oaks General Hospital","funders":"","keywords":"Type 2 diabetes; Kidney disease; Diabetes mellitus; Psychological intervention; Health care; Disease; Identification (biology)","score_opus":0.003586347832588687,"score_gpt":0.2541781987907708,"score_spread":0.2505918509581821,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414523792","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9514998,0.04681426,0.0000015763037,0.00009112486,0.000055244625,0.0011034276,0.0003530348,0.000020871921,0.000060660597],"genre_scores_gemma":[0.997528,0.0016186488,0.00013626083,0.000250782,0.000029505985,0.000080714635,0.00031923063,0.00002081645,0.000016000762],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99915534,0.000033117114,0.0001924779,0.0002456867,0.00014463918,0.00022872697],"domain_scores_gemma":[0.9989172,0.00015739008,0.00012500396,0.0002485537,0.0002832138,0.00026860216],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006695203,0.00016481012,0.00038684712,0.00010110828,0.00005988048,0.000009507811,0.00005154561,0.000055289613,0.000016190792],"category_scores_gemma":[0.00021969105,0.00011445836,0.000060978222,0.00016248229,0.00019594905,0.00005761554,0.000030446568,0.000056683464,2.0764074e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00066960085,0.0002646379,0.9012998,0.001552078,0.00027050087,1.3244325e-7,0.00010102273,4.136233e-7,0.0015356245,0.000049423685,0.00033125095,0.09392554],"study_design_scores_gemma":[0.012366053,0.0037867217,0.94641584,0.0029091474,0.00058363937,9.5653645e-9,0.000054124495,0.00024193164,0.031041436,0.00021427027,0.002197049,0.00018976245],"about_ca_topic_score_codex":0.0000017685013,"about_ca_topic_score_gemma":9.116247e-7,"teacher_disagreement_score":0.093735784,"about_ca_system_score_codex":0.00004719886,"about_ca_system_score_gemma":0.0003688689,"threshold_uncertainty_score":0.46674764},"labels":[],"label_agreement":null},{"id":"W4414861752","doi":"10.1007/s13300-025-01802-y","title":"The Mechanisms of Inflammatory Factors and the Total Load of Cerebral Small Vessel Disease in Diabetic Retinopathy and Cognitive Impairment","year":2025,"lang":"en","type":"article","venue":"Diabetes Therapy","topic":"Retinal Diseases and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cognitive impairment; Diabetes mellitus; Diabetic retinopathy; Disease; Retinopathy; Inflammation","score_opus":0.005877679644078948,"score_gpt":0.2288710978266742,"score_spread":0.22299341818259524,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414861752","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98707235,0.011649669,0.000003442176,0.0002724124,0.000052691907,0.0008426382,0.000039228697,0.0000069436232,0.000060637365],"genre_scores_gemma":[0.99888265,0.00088366197,0.000004826129,0.00007735387,0.0000063808416,0.00007503984,0.000008922231,0.000009130915,0.000052029693],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991867,0.00011292291,0.00022659592,0.00015465738,0.00014722013,0.00017193294],"domain_scores_gemma":[0.9991575,0.00043980128,0.00009298921,0.0001595996,0.00007003115,0.00008011651],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019105813,0.00014127934,0.00028213864,0.000037351503,0.000058943057,0.000016000235,0.00005044956,0.00003151516,0.000004734086],"category_scores_gemma":[0.00008244808,0.00006916384,0.00007894859,0.00009404027,0.000342173,0.000023714932,0.000041504667,0.00006986694,2.2902329e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017629403,0.00023065717,0.99087197,0.0001322925,0.00026627036,0.0000038664307,0.00047350515,0.0000011367579,0.0006371906,0.0018674711,0.0000033317103,0.0037493804],"study_design_scores_gemma":[0.005869013,0.00034655703,0.9841076,0.00029856383,0.00017099464,1.366473e-7,0.00043410857,0.00020201635,0.0047752806,0.0037337707,0.000004427231,0.000057543963],"about_ca_topic_score_codex":0.000033816254,"about_ca_topic_score_gemma":0.0000017702607,"teacher_disagreement_score":0.011810319,"about_ca_system_score_codex":0.00001965426,"about_ca_system_score_gemma":0.00008573299,"threshold_uncertainty_score":0.28204194},"labels":[],"label_agreement":null},{"id":"W4415951323","doi":"10.1007/s13300-025-01804-w","title":"Insights into the Mechanism of Action of Tirzepatide: A Narrative Review","year":2025,"lang":"en","type":"review","venue":"Diabetes Therapy","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Eli Lilly (Canada); University of Toronto","funders":"Eli Lilly and Company","keywords":"Narrative review; Type 2 diabetes; Heart failure; Weight loss; Overweight; Glycemic; Mechanism (biology); Diabetes mellitus; Agonist","score_opus":0.04136549460698956,"score_gpt":0.3543042300904666,"score_spread":0.312938735483477,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415951323","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002645624,0.99410677,0.000005558159,0.00016595358,0.00021676575,0.0033679372,0.000006852221,0.000028907927,0.0018366798],"genre_scores_gemma":[0.00013940853,0.9970684,0.00008208425,0.00048372213,0.000048159047,0.0007064376,0.00018353744,0.000030483672,0.0012577398],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99826556,0.00024947795,0.0007203154,0.00029661477,0.00029605662,0.0001719814],"domain_scores_gemma":[0.9981219,0.00030635425,0.0006767938,0.0006976474,0.00015641908,0.00004084059],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023693363,0.00038975323,0.0024060467,0.00024019304,0.00005104823,0.000006454711,0.00024434083,0.0001425595,0.0000951343],"category_scores_gemma":[0.000065195905,0.0002052503,0.0007646947,0.0006610672,0.000084241896,0.00004954916,0.00006470658,0.00017975172,0.00001011624],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00000545295,0.00017519694,0.0000036161389,0.09180676,0.0018731103,7.6653504e-7,0.00044389418,1.2594808e-8,0.000018840672,0.0015205867,0.0013865902,0.90276515],"study_design_scores_gemma":[0.00043287457,0.0005074821,0.000004953872,0.12639634,0.0029559624,1.0205998e-7,0.00005479533,0.0000013021934,0.0007019205,0.00076760526,0.86802423,0.00015245761],"about_ca_topic_score_codex":0.000008583438,"about_ca_topic_score_gemma":0.0000033627455,"teacher_disagreement_score":0.9026127,"about_ca_system_score_codex":0.00008375218,"about_ca_system_score_gemma":0.0001895313,"threshold_uncertainty_score":0.8369864},"labels":[],"label_agreement":null},{"id":"W4416776298","doi":"10.1007/s13300-025-01820-w","title":"Correction to: Quantifying Patient Preferences for Basal Insulin Treatments in Adults Living with Type 2 Diabetes: A Discrete Choice Experiment in Canada, Spain, France, and Japan","year":2025,"lang":"en","type":"article","venue":"Diabetes Therapy","topic":"Economic and Environmental Valuation","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Basal insulin; Type 2 diabetes; Diabetes mellitus; Basal (medicine); Type 1 diabetes","score_opus":0.03299408598097522,"score_gpt":0.22368033856492103,"score_spread":0.1906862525839458,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416776298","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99547,0.0031098193,0.000025195208,0.00006273715,0.00041317838,0.0006032966,0.000028228527,0.000006083312,0.00028148462],"genre_scores_gemma":[0.9986316,0.00035084973,0.00014618822,0.00040259407,0.000013211833,0.00035225053,0.000017665732,0.000012928352,0.000072698276],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990596,0.000018403416,0.000322464,0.00033957782,0.000023944534,0.00023596402],"domain_scores_gemma":[0.99956644,0.0001659768,0.00011013485,0.000112815236,0.000006878523,0.00003777605],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014343132,0.00013646358,0.000259491,0.00014639992,0.000049292572,0.000026935291,0.000062682,0.000032951844,0.000028932964],"category_scores_gemma":[0.000039020753,0.00013707789,0.00001838728,0.00016002225,0.00001517435,0.00012774725,0.000018634692,0.000056182314,0.0000034052111],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002695717,0.000060744507,0.9796907,0.000016028353,0.00003182772,4.0130818e-8,0.0008923228,0.0005135922,0.00004043711,0.00003604555,0.00005030608,0.01864105],"study_design_scores_gemma":[0.0009799062,0.00035727528,0.98853546,0.0002774794,0.0000017809833,8.035079e-9,0.0004500752,0.00836275,0.00051903754,0.00012375813,0.0002335214,0.00015892732],"about_ca_topic_score_codex":0.07737024,"about_ca_topic_score_gemma":0.17553204,"teacher_disagreement_score":0.09816181,"about_ca_system_score_codex":0.0004167743,"about_ca_system_score_gemma":0.000042781005,"threshold_uncertainty_score":0.92877364},"labels":[],"label_agreement":null},{"id":"W4416776419","doi":"10.1007/s13300-025-01821-9","title":"Cost-effectiveness of Freestyle Libre Systems for People with Type 2 Diabetes Mellitus on Basal Insulin Therapy in the Netherlands: An Economic Evaluation from a Societal Perspective Within a Publicly Funded Healthcare System","year":2025,"lang":"en","type":"article","venue":"Diabetes Therapy","topic":"Diabetes Management and Education","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"Abbott Diabetes Care","keywords":"Type 2 Diabetes Mellitus; Perspective (graphical); Healthcare system; Health care; Economic evaluation; Basal insulin; Type 2 diabetes","score_opus":0.05050749177980778,"score_gpt":0.33954838286225153,"score_spread":0.28904089108244374,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416776419","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9825718,0.00869835,0.000025285866,0.0008578221,0.0006135283,0.006801694,0.0000708508,0.00006906422,0.0002916148],"genre_scores_gemma":[0.9959166,0.0002578076,0.000055078886,0.00044447376,0.00020678143,0.0024826622,0.0005714663,0.00004564566,0.000019459876],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99748737,0.0009007501,0.00039097108,0.00052790827,0.00031980788,0.000373202],"domain_scores_gemma":[0.99780196,0.0008623197,0.0002631626,0.0005766576,0.00042984632,0.00006606424],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025359867,0.00028828994,0.00064829434,0.00024302749,0.00011471469,0.00014084099,0.0002740767,0.00014387451,0.000013102479],"category_scores_gemma":[0.000058995996,0.00019500764,0.00011037084,0.00051801215,0.000067659006,0.0002578246,0.000013168062,0.00018882187,0.0000037845323],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005137283,0.0018222022,0.9292387,0.0013742035,0.0018282663,5.399988e-7,0.018362924,0.002114519,0.0013765595,0.008926882,0.0006235634,0.02919438],"study_design_scores_gemma":[0.017837815,0.009529893,0.8565745,0.0020857109,0.0002680473,1.8711496e-7,0.03997158,0.06452201,0.005434971,0.0028573805,0.00040638188,0.00051155745],"about_ca_topic_score_codex":0.0011331493,"about_ca_topic_score_gemma":0.00036737826,"teacher_disagreement_score":0.07266421,"about_ca_system_score_codex":0.00060139067,"about_ca_system_score_gemma":0.000411382,"threshold_uncertainty_score":0.7952181},"labels":[],"label_agreement":null}]}